Sulfonylaminobenzamide compound and pest control agent

Abstract

A compound represented by formula (I) or a salt thereof.

Description

TECHNICAL FIELD

The present invention relates to a sufonylaminobenzamide compound and a pest control agent. More specifically, the present invention relates to a sufonylaminobenzamide compound that has excellent insecticidal activity, miticidal activity and/or nematicidal activity, exhibits excellent safety, and can be synthesized favorably on an industrial scale, and also relates to a pest control agent that contains this compound as an active constituent.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is the U.S. National Stage of PCT/JP2017/030739, filed Aug. 28, 2017, which claims priority on Japanese Patent Application No. 2016-167859, filed in Japan on Aug. 30, 2016, the content of which is incorporated herein by reference.

BACKGROUND ART

Many compounds having insecticidal, miticidal and/or nematicidal activity have been proposed. In order to enable these types of compounds to be used as agricultural chemicals, they must not only have sufficiently high potency, but must also be resistant to the development of drug resistance, cause no chemical damage to plants and no soil contamination, and exhibit low toxicity relative to domestic animals and fish and the like.

A compound represented by formula (A) is disclosed in Patent Document 1. Further, a compound represented by formula (B) is disclosed in Patent Document 2. According to Patent Document 1 and Patent Document 2, these compounds are apparently useful as parasiticides.

PRIOR ART LITERATURE

Patent Documents

Patent Document 1: WO 2015/195423 A1

Patent Document 2: WO 2016/033341 A1

SUMMARY OF THE INVENTION

Problems to be Solved by the Invention

Objects of the present invention are to provide a sufonylaminobenzamide compound that has pest control activity, and in particular, has excellent insecticidal, miticidal and/or nematicidal activity, exhibits excellent safety, and can be synthesized favorably on an industrial scale, and also to provide a pest control agent that contains this compound as an active constituent.

Means for Solving the Problems

As a result of intensive investigation aimed at achieving the above objects, the inventors were able to complete the present invention having the aspects described below.

[1] A compound represented by formula (I) or a salt thereof.

In formula (I),

R¹ and R⁴ each independently represent a hydrogen atom, unsubstituted or substituted C1 to C6 alkyl group, halogeno group or cyano group.

R² represents a hydrogen atom, unsubstituted or substituted C1 to C6 alkyl group, unsubstituted or substituted C1 to C6 alkoxy group, halogeno group, cyano group, unsubstituted or substituted C1 to C6 alkylcarbonyl group, unsubstituted or substituted C1 to C6 alkoxycarbonyl group, unsubstituted or substituted C1 to C6 alkylthio group, unsubstituted or substituted C1 to C6 alkylsulfinyl group, unsubstituted or substituted C1 to C6 alkylsulfonyl group, group represented by —NR^aR^b, or group represented by —(C═O)—NR^cR^d.

R³ represents an unsubstituted or substituted C1 to C6 alkyl group, unsubstituted or substituted C2 to C6 alkenyl group, unsubstituted or substituted C2 to C6 alkynyl group, hydroxyl group, unsubstituted or substituted C1 to C6 alkoxy group, formyl group, unsubstituted or substituted C1 to C6 alkylcarbonyl group, carboxyl group, unsubstituted or substituted C1 to C6 alkoxycarbonyl group, unsubstituted or substituted C1 to C6 alkylcarbonyloxy group, mercapto group, unsubstituted or substituted C1 to C6 alkylthio group, unsubstituted or substituted C1 to C6 alkylsulfinyl group, unsubstituted or substituted C1 to C6 alkylsulfonyl group, unsubstituted or substituted C3 to C8 cycloalkyl group, unsubstituted or substituted C6 to C10 aryl group, unsubstituted or substituted heteroaryl group, unsubstituted or substituted C6 to C10 aryloxy group, unsubstituted or substituted heteroaryloxy group, halogeno group, nitro group, cyano group, group represented by —NR^aR^b, group represented by —(C═O)—NR^cR^d, or group represented by —O—(C═O)—NR^cR^d.

R^a and R^b each independently represent a hydrogen atom, unsubstituted or substituted C1 to C6 alkyl group, unsubstituted or substituted C1 to C6 alkylcarbonyl group, or unsubstituted or substituted C1 to C6 alkoxycarbonyl group.

R^c and R^d each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group.

R² and R³ may be linked together to form, in combination with the carbon atoms to which they are bonded, an unsubstituted or substituted 5- or 6-membered ring.

R⁵ represents a C1 to C6 haloalkyl group, C3 to C8 halocycloalkyl group, or C3 to C8 halocycloalkyl C1 to C6 alkyl group.

G represents an oxygen atom or a sulfur atom.

R⁶ and R⁷ each independently represent a hydrogen atom, unsubstituted or substituted C1 to C6 alkyl group, unsubstituted or substituted C1 to C6 alkylcarbonyl group, unsubstituted or substituted C1 to C6 alkoxycarbonyl group, unsubstituted or substituted C3 to C8 cycloalkyl group, unsubstituted or substituted C3 to C8 cycloalkylcarbonyl group, or unsubstituted or substituted C3 to C8 cycloalkoxycarbonyl group.

n represents 0 or 1.

R⁸ and R⁹ each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group.

Ar represents an unsubstituted or substituted C6 to C10 aryl group or an unsubstituted or substituted 5- or 6-membered heteroaryl group.

[2] A pest control agent containing at least one substance selected from the group consisting of the compound disclosed above in [1] and salts thereof as an active constituent.

[3] An insecticide or miticide containing at least one substance selected from the group consisting of the compound disclosed above in [1] and salts thereof as an active constituent.

[4] A nematicide containing at least one substance selected from the group consisting of the compound disclosed above in [1] and salts thereof as an active constituent.

[5] An endoparasite control agent or parasiticide containing at least one substance selected from the group consisting of the compound disclosed above in [1] and salts thereof as an active constituent.

Effects of the Invention

The sufonylaminobenzamide compound of the present invention has pest control activity, and in particular, has excellent insecticidal, miticidal and/or nematicidal activity, exhibits excellent safety, and can be synthesized favorably on an industrial scale.

The pest control agent of the present invention can control pests that have a harmful effect on crops and pests that are problematic from a sanitation perspective. The pest control agent of the present invention exhibits an excellent control effect on agricultural pests even at low concentrations.

EMBODIMENTS FOR CARRYING OUT THE INVENTION

The sufonylamninobenzamide compound of the present invention is a compound represented by formula (I) (hereafter also referred to as the compound (I)) or a salt of the compound (1).

Firstly, in the present invention, the term “unsubstituted” means only the core group. When the term “substituted” does not appear and only the name of the core group is recorded, the meaning “unsubstituted” is implied unless specifically stated otherwise.

On the other hand, the term “substituted” means that one of the hydrogen atoms of the core group has been substituted with a group having a structure either the same as, or different from, the core group. Accordingly, the “substituent” is another group that is bonded to the core group. There may be either one substituent, or two or more substituents. In the case of two or more substituents, the substituents may be the same or different.

There are no particular limitations on the “substituent”, provided it is chemically permissible and yields a compound having the effects of the present invention.

Specific examples of groups that can become a “substituent” include the groups listed below.

Halogeno groups such as a fluoro group, chloro group, bromo group, and iodo group;

C1 to C6 alkyl groups such as a methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, and n-hexyl group;

C2 to C6 alkenyl groups such as a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, and 5-hexenyl group;

C2 to C6 alkynyl groups such as an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, and 1,1-dimethyl-2-butynyl group;

C3 to C8 cycloalkyl groups such as a cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, cycloheptyl group, and cubanyl group;

C3 to C8 cycloalkenyl groups such as a 2-cyclopropenyl group, 2-cyclopentenyl group, 3-cyclohexenyl group, and 4-cyclooctenyl group;

C6 to C10 aryl groups such as a phenyl group and naphthyl group;

5-membered heteroaryl groups such as a pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, and tetrazolyl group;

6-membered heteroaryl groups such as a pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, and triazinyl group;

condensed ring heteroaryl groups such as an indolyl group, benzofuryl group, benzothienyl group, benzoimidazolyl group, benzoxazolyl group, benzothiazolyl group, quinolyl group, isoquinolyl group, and quinoxalinyl group;

cyclic ether groups such as an oxiranyl group, tetrahydrofuryl group, dioxolanyl group, and dioxanyl group;

cyclic amino groups such as an aziridinyl group, pyrrolidinyl group, piperidinyl group, piperazinyl group, and morpholinyl group;

a hydroxyl group; an oxo group;

C1 to C6 alkoxy groups such as a methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, and t-butoxy group;

C2 to C6 alkenyloxy groups such as a vinyloxy group, allyloxy group, propenyloxy group, and butenyloxy group;

C2 to C6 alkynyloxy groups such as an ethynyloxy group and propargyloxy group;

C6 to C10 aryloxy groups such as a phenoxy group and naphthoxy group;

5- to 6-membered ring heteroaryloxy groups such as a thiazolyloxy group and pyridyloxy group;

a carboxyl group;

C1 to C6 alkylcarbonyl groups such as a formyl group, acetyl group, and propionyl group;

C1 to C6 alkylcarbonyloxy groups such as a formyloxy group, acetyloxy group, and propionyloxy group;

C1 to C6 alkoxycarbonyl groups such as a methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, and t-butoxycarbonyl group;

C1 to C6 haloalkyl groups such as a chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, and perfluoro-n-pentyl group;

C2 to C6 haloalkenyl groups such as a 2-chloro-1-propenyl group and 2-fluoro-1-butenyl group;

C2 to C6 haloalkynyl groups such as a 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, and 5-bromo-2-pentynyl group;

C3 to C6 halocycloalkyl groups such as a 3,3-difluorocyclobutyl group;

C1 to C6 haloalkoxy groups such as a 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, and 2,2,2-trifluoroethoxy group;

C2 to C6 haloalkenyloxy groups such as a 2-chloropropenyloxy group and 3-bromobutenyloxy group;

C1 to C6 haloalkylcarbonyl groups such as a chloroacetyl group, trifluoroacetyl group, and trichloroacetyl group;

a cyano group; a nitro group; an amino group;

C1 to C6 alkylamino groups such as a methylamino group, dimethylamino group, and diethylamino group;

C6 to C10 arylamino groups such as an anilino group and naphthylamino group;

C1 to C6 alkylcarbonylamino groups such as a formylamino group, acetylamino group, propanoylamino group, butyrylamino group, and i-propylcarbonylamino group;

C1 to C6 alkoxycarbonylanmino groups such as a methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, and i-propoxycarbonylamino group;

C1 to C6 alkylsulfoxyimino groups such as an S,S-dimethylsulfoxyimino group;

an aminocarbonyl group;

C1 to C6 alkylaminocarbonyl groups such as a methylaminocarbonyl group, dimethylaminocarbonyl group, ethylaminocarbonyl group, and i-propylaminocarbonyl group;

imino C1 to C6 alkyl groups such as an iminomethyl group, (1-imino)ethyl group, and (1-imino)-n-propyl group;

C1 to C6 alkoxyaminocarbonyl groups such as a methoxyaminocarbonyl group, ethoxyaminocarbonyl group, and i-propoxyaminocarbonyl group;

hydroxyimino C1 to C6 alkyl groups such as a hydroxyinminomethyl group, (1-hydroxyimino)ethyl group, and (1-hydroxyimino)propyl group;

C1 to C6 alkoxyimino C1 to C6 alkyl groups such as a methoxyiminomethyl group and (1-methoxyimino)ethyl group;

a mercapto group;

a pentafluorosulfanyl group;

C1 to C6 alkylthio groups such as a methylthio group, ethylthio group, n-propylthio group, i-propylthio group, n-butylthio group, i-butylthio group, s-butylthio group, and t-butylthio group;

C1 to C6 haloalkylthio groups such as a trifluoromethylthio group and 2,2,2-trifluoroethylthio group;

C2 to C6 alkenylthio groups such as a vinylthio group and allylthio group;

C2 to C6 alkynylthio groups such as an ethynylthio group and propargylthio group;

C1 to C6 alkylsulfinyl groups such as a methylsulfinyl group, ethylsulfinyl group, and t-butylsulfinyl group;

C1 to C6 haloalkylsulfinyl groups such as a trifluoromethylsulfinyl group and 2,2,2-trifluoroethylsulfinyl group;

C2 to C6 alkenylsulfinyl groups such as an allylsulfinyl group;

C2 to C6 alkynylsulfinyl groups such as a propargylsulfinyl group;

C1 to C6 alkylsulfonyl groups such as a methylsulfonyl group, ethylsulfonyl group, and t-butylsulfonyl group;

C1 to C6 haloalkylsulfonyl groups such as a trifluoromrethylsulfonyl group and 2,2,2-trifluoroethylsulfonyl group;

C2 to C6 alkenylsulfonyl groups such as an allylsulfonyl group;

C2 to C6 alkynylsulfonyl groups such as a propargylsulfonyl group;

tri C1 to C6 alkylsilyl groups such as a trimethylsilyl group, triethylsilyl group, and t-butyldimethylsilyl group; and

tri C6 to C10 arylsilyl groups such as a triphenylsilyl group.

Further, in these “substituents”, any of the hydrogen atoms in any of the above substituents may be substituted with a group of a different structure. Examples of the “substituents” in such cases include C1 to C6 alkyl groups, C1 to C6 haloalkyl groups, C1 to C6 alkoxy groups, C1 to C6 haloalkoxy groups, halogeno groups, a cyano group and a nitro group.

Terms such as “C1 to C6” indicate that the number of carbon atoms in the core group is from 1 to 6 or the like. This number of carbon atoms does not include the number of carbon atoms that exist within substituents. For example, in the case of an ethoxybutyl group, the core group is a butyl group and the ethoxy group is a substituent, and therefore this group is classified as a C2 alkoxy C4 alkyl group.

In formula (I), R¹ and R⁴ each independently represent a hydrogen atom, unsubstituted or substituted C1 to C6 alkyl group, halogeno group or cyano group.

The “C1 to C6 alkyl group” for R¹ and R⁴ may be linear or branched. Examples of the alkyl group include a methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s-butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, 2,2-dimethylbutyl group, and i-hexyl group.

Examples of preferred substituents on the “C1 to C6 alkyl group” of R¹ and R⁴ include halogeno groups such as a fluoro group, chloro group, bromo group, and iodo group; C1 to C6 alkoxy groups such as a methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, and t-butoxy group; C1 to C6 haloalkoxy groups such as a 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, and trifluoromethoxy group; and a cyano group.

Examples of the halogeno group for R¹ and R⁴ include a fluoro group, chloro group, bromo group, and iodo group.

R¹ and R⁴ are preferably hydrogen atoms.

In formula (I), R² represents a hydrogen atom, unsubstituted or substituted C1 to C6 alkyl group, unsubstituted or substituted C1 to C6 alkoxy group, halogeno group, cyano group, unsubstituted or substituted C1 to C6 alkylcarbonyl group, unsubstituted or substituted C1 to C6 alkoxycarbonyl group, unsubstituted or substituted C1 to C6 alkylthio group, unsubstituted or substituted C1 to C6 alkylsulfinyl group, unsubstituted or substituted C1 to C6 alkylsulfonyl group, group represented by —NR^aR^b, or group represented by —(C═O)—NR^cR^d.

Examples of the “unsubstituted or substituted C1 to C6 alkyl group” and the “halogeno group” for R² include the same groups as those exemplified above for R¹ and R⁴.

Examples of the “C1 to C6 alkoxy group” for R² include a methoxy group, ethoxy group, n-propoxy group, n-butoxy group, n-pentyloxy group, n-hexyloxy group, i-propoxy group, i-butoxy group, s-butoxy group, t-butoxy group, and i-hexyloxy group.

Examples of the “C1 to C6 alkylcarbonyl group” for R² include an acetyl group and propionyl group.

Examples of the “C1 to C6 alkoxycarbonyl group” for R² include a methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, and t-butoxycarbonyl group.

Examples of the “C1 to C6 alkylthio group” for R² include a methylthio group, ethylthio group, n-propylthio group, n-butylthio group, n-pentylthio group, n-hexylthio group, and i-propylthio group.

Examples of the “C1 to C6 alkylsulfinyl group” for R² include a methylsulfinyl group, ethylsulfinyl group, and t-butylsulfinyl group.

Examples of the “C1 to C6 alkylsulfonyl group” for R² include a methylsulfonyl group, ethylsulfonyl group, and t-butylsulfonyl group.

Examples of preferred substituents on the “C1 to C6 alkoxy group”, “C1 to C6 alkylcarbonyl group”, “C1 to C6 alkoxycarbonyl group”, “C1 to C6 alkylthio group”, “C1 to C6 alkylsulfinyl group” and “C1 to C6 alkylsulfonyl group” for R² include halogeno groups such as a fluoro group, chloro group, bromo group, and iodo group; C1 to C6 alkoxy groups such as a methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, and t-butoxy group; C1 to C6 haloalkoxy groups such as a 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, and trifluoromethoxy group; and a cyano group.

R^a and R^b in the “group represented by —NR^aR^b” for R² each independently represent a hydrogen atom, unsubstituted or substituted C1 to C6 alkyl group, unsubstituted or substituted C1 to C6 alkylcarbonyl group, or unsubstituted or substituted C1 to C6 alkoxycarbonyl group. Examples of the “C1 to C6 alkyl group” for R^a and R^b include the same groups as those exemplified above for R¹ and R⁴. Examples of the “C1 to C6 alkylcarbonyl group” and the “C1 to C6 alkoxycarbonyl group” for R^a and R^b include the same groups as those exemplified above for R². Examples of preferred substituents on the “C1 to C6 alkyl group”, “C1 to C6 alkylcarbonyl group” and “C1 to C6 alkoxycarbonyl group” for R^a and R^b include halogeno groups such as a fluoro group, chloro group, bromo group and iodo group, or a cyano group.

R^c and R^d in the “group represented by —(C═O)—NR^cR^d” for R² each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group. Examples of the “unsubstituted or substituted C1 to C6 alkyl group” for R^c and R^d include the same groups as those exemplified above for R^a and R^b.

R² is preferably a hydrogen atom, unsubstituted or substituted C1 to C6 alkyl group (and preferably a substituted C1 to C6 alkyl group), or halogeno group.

In formula (I), R³ represents an unsubstituted or substituted C1 to C6 alkyl group, unsubstituted or substituted C2 to C6 alkenyl group, unsubstituted or substituted C2 to C6 alkynyl group, hydroxyl group, unsubstituted or substituted C1 to C6 alkoxy group, formyl group, unsubstituted or substituted C1 to C6 alkylcarbonyl group, carboxyl group, unsubstituted or substituted C1 to C6 alkoxycarbonyl group, unsubstituted or substituted C1 to C6 alkylcarbonyloxy group, mercapto group, unsubstituted or substituted C1 to C6 alkylthio group, unsubstituted or substituted C1 to C6 alkylsulfinyl group, unsubstituted or substituted C1 to C6 alkylsulfonyl group, unsubstituted or substituted C3 to C8 cycloalkyl group, unsubstituted or substituted C6 to C10 aryl group, unsubstituted or substituted heteroaryl group, unsubstituted or substituted C6 to C10 aryloxy group, unsubstituted or substituted heteroaryloxy group, halogeno group, nitro group, cyano group, group represented by —NR^aR^b, group represented by —(C═O)—NR^cR^d, or group represented by —O—(C═O)—NR^cR^d.

Examples of the “unsubstituted or substituted C1 to C6 alkyl group” and the “halogeno group” for R³ include the same groups as those exemplified above for R¹ and R⁴.

Examples of the “unsubstituted or substituted C1 to C6 alkoxy group”, “unsubstituted or substituted C1 to C6 alkylcarbonyl group”, “unsubstituted or substituted C1 to C6 alkoxycarbonyl group”, “unsubstituted or substituted C1 to C6 alkylthio group”, “unsubstituted or substituted C1 to C6 alkylsulfinyl group” and “unsubstituted or substituted C1 to C6 alkylsulfonyl group” for R³ include the same groups as those exemplified above for R².

Examples of the “C2 to C6 alkenyl group” for R³ include a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group and 5-hexenyl group.

Examples of the “C2 to C6 alkynyl group” for R³ include an ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, and 1,1-dimethyl-2-butynyl group.

Examples of the “C1 to C6 alkylcarbonyloxy group” for R³ include an acetyloxy group, propionyloxy group, and butyryloxy group.

Examples of preferred substituents on the “C2 to C6 alkenyl group”, “C2 to C6 alkynyl group” and “C1 to C6 alkylcarbonyloxy group” for R³ include halogeno groups such as a fluoro group, chloro group, bromo group, and iodo group; C1 to C6 alkoxy groups such as a methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, and t-butoxy group; C1 to C6 haloalkoxy groups such as a 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, and trifluoromethoxy group; and a cyano group.

Examples of the “C3 to C8 cycloalkyl group” for R³ include a cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, and cycloheptyl group.

The “C6 to C10 aryl group” for R³ may be a monocyclic aryl group or a polycyclic aryl group. In a polycyclic group, provided at least one ring is an aromatic ring, each remaining ring may be a saturated alicyclic ring, unsaturated alicyclic ring or aromatic ring.

Examples of the “C6 to C10 aryl group” include a phenyl group, naphthyl group, azulenyl group, indenyl group, indanyl group, and tetralinyl group.

Examples of the “heteroaryl group” for R³ include 5-membered heteroaryl groups such as a pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group (and specifically, a [1,2,3]-triazolyl group or [1,2,4]-triazolyl group), oxadiazolyl group (and specifically, a [1,2,3]-oxadiazolyl group, [1,2,4]-oxadiazolyl group, [1,2,5]-oxadiazolyl group or [1,3,4]-oxadiazolyl group), thiadiazolyl group, and tetrazolyl group; 6-membered heteroaryl groups such as a pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, and triazinyl group; and condensed ring heteroaryl groups such as an indolyl group, benzofuryl group, benzothienyl group, benzoimidazolyl group, benzoxazolyl group, benzothiazolyl group, quinolyl group, isoquinolyl group, and quinoxalinyl group.

Examples of the “C6 to C10 aryloxy group” for R³ include a phenoxy group, naphthyloxy group, azulenyloxy group, indenyloxy group, indanyloxy group, and tetralinyloxy group.

Examples of the “heteroaryloxy group” for R³ include 5- and 6-membered heteroaryloxy groups such as a thiazolyloxy group and pyridyloxy group.

Examples of preferred substituents on the “C3 to C8 cycloalkyl group”, “C6 to C10 aryl group”, “heteroaryl group”, “C6 to C10 aryloxy group” and “heteroaryloxy group” for R³ include halogeno groups such as a fluoro group, chloro group, bromo group, and iodo group; C1 to C6 alkyl groups such as a methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, and n-hexyl group; C1 to C6 haloalkyl groups such as a chloromethyl group, chloroethyl group, trifluoromethyl group, pentafluoroethyl group, 1,2-dichloro-n-propyl group, 1,1,1,3,3,3-hexafluoropropan-2-yl group, perfluoropropan-2-yl group, 1-fluoro-n-butyl group, and perfluoro-n-pentyl group; C1 to C6 alkoxy groups such as a methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, and t-butoxy group; C1 to C6 haloalkoxy groups such as a 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, and trifluoromethoxy group; a cyano group; and a pentafluorosulfanyl group, and examples of particularly preferred substituents include halogeno groups such as a fluoro group, chloro group, bromo group, and iodo group; and C1 to C6 haloalkyl groups such as a chloromethyl group, chloroethyl group, trifluoromethyl group, pentafluoroethyl group, 1,2-dichloro-n-propyl group, 1,1,1,3,3,3-hexafluoropropan-2-yl group, perfluoropropan-2-yl group, 1-fluoro-n-butyl group, and perfluoro-n-pentyl group.

R^a and R^b in the “group represented by —NR^aR^b” for R³ each independently represent a hydrogen atom, unsubstituted or substituted C1 to C6 alkyl group, unsubstituted or substituted C1 to C6 alkylcarbonyl group, or unsubstituted or substituted C1 to C6 alkoxycarbonyl group.

Examples of the “unsubstituted or substituted C1 to C6 alkyl group”, “unsubstituted or substituted C1 to C6 alkylcarbonyl group” and “unsubstituted or substituted C1 to C6 alkoxycarbonyl group” for R^a and R^b in the “group represented by —NR^aR^b” for R³ include the same groups as those exemplified above for R^a and R^b in the “group represented by —NR^aR^b” for R².

R^c and R^d in the “group represented by —(C═O)—NR^cR^d” and the “group represented by —O—(C═O)—NR^cR^d” for R³ each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group. Examples of the “unsubstituted or substituted C1 to C6 alkyl group” for R^c and R^d in the “group represented by —(C═O)—NR^cR^d” and the “group represented by —O—(C═O)—NR^cR^d” for R³ include the same groups as those exemplified above for R^c and R^d in the “group represented by —(C═O)—NR^cR^d” for R².

R³ is preferably an unsubstituted or substituted C1 to C6 alkyl group, unsubstituted or substituted C1 to C6 alkoxy group (and preferably a substituted C1 to C6 alkoxy group), unsubstituted or substituted C6 to C10 aryl group (and preferably an unsubstituted or substituted phenyl group), unsubstituted or substituted heteroaryl group (and preferably an unsubstituted or substituted 5- or 6-membered heteroaryl group), halogeno group, nitro group, or cyano group.

The “5- or 6-membered heteroaryl group” for R³ is preferably a triazolyl group or pyridyl group.

In formula (I), R² and R³ may be linked together to form, in combination with the carbon atoms to which they are bonded, an unsubstituted or substituted 5- or 6-membered ring.

Examples of the 5- or 6-membered ring formed by R², R³ and the carbon atoms to which they are bonded include 1,3-dioxolane, tetrahydrofuran, piperidine, piperazine, morpholine, 1,4-oxathiane, 1,4-oxathiane, 4,4-dioxide, thiomorpholine, cyclohexane, piperidin-2-one, thiomorpholin-3-one, and cyclohexanone. Examples of preferred substituents on the 5- or 6-membered ring include halogeno groups.

In formula (I), R⁵ represents a C1 to C6 haloalkyl group, C3 to C8 halocycloalkyl group, or C3 to C8 halocycloalkyl C1 to C6 alkyl group.

Examples of the “C1 to C6 haloalkyl group” for R⁵ include a fluoromethyl group, chloromethyl group, bromomethyl group, iodomethyl group, difluoromethyl group, dichloromethyl group, trifluoromethyl group, chlorodifluoromethyl group, trichloromethyl group, bromodifluoromethyl group, 2-fluoroethyl group, 2-chloroethyl group, 2-bromoethyl group, 2,2-difluoroethyl group, 2,2,2-trifluoroethyl group, 2-chloro-2,2-difluoroethyl group, 2,2,2-trichloroethyl group, 1,1,2,2-tetrafluoroethyl group, 2-chloro-1,1,2-trifluoroethyl group, pentafluoroethyl group, 3,3,3-trifluoropropyl group, 2,2,3,3,3-pentafluoropropyl group, 1,1,2,3,3,3-hexafluoropropyl group, heptafluoropropyl group, 2,2,2-trifluoro-1-(trifluoromethyl)ethyl group, 1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl group, 2,2,3,3,4,4,4-heptafluorobutyl group, and nonafluorobutyl group.

Examples of the “C3 to C8 halocycloalkyl group” for R⁵ include a 1-fluorocyclopropyl group, 2-fluorocyclopropyl group, 1-chlorocyclopropyl group, 2-chlorocyclopropyl group, 2,2-difluorocyclopropyl group, 2,2-dichlorocyclopropyl group, 2,2,3,3-tetrafluorocyclopropyl group, 2-fluorocyclopentyl group, 3-fluorocyclopentyl group, 2-chlorocyclopentyl group, 3-chlorocyclopentyl group, 3,4-difluorocyclohexyl group, 3,4-dichlorocyclohexyl group, and 3,4-dibromocyclohexyl group.

Examples of the “C3 to C8 halocycloalkyl C1 to C6 alkyl group” for R⁵ include a 2-fluorocyclopropylmethyl group, 1-fluorocyclopropylmethyl group, 1,2-difluorocyclopropylmethyl group, and 2,2,3,3-tetrafluorocyclopropylmethyl group.

R⁵ is preferably a C1 to C6 haloalkyl group, and more preferably a C1 to C4 haloalkyl group.

In formula (I), G represents an oxygen atom or a sulfur atom.

G is preferably an oxygen atom.

In formula (I), R⁶ and R⁷ each independently represent a hydrogen atom, unsubstituted or substituted C1 to C6 alkyl group, unsubstituted or substituted C1 to C6 alkylcarbonyl group, unsubstituted or substituted C1 to C6 alkoxycarbonyl group, unsubstituted or substituted C3 to C8 cycloalkyl group, unsubstituted or substituted C3 to C8 cycloalkylcarbonyl group, or unsubstituted or substituted C3 to C8 cycloalkoxycarbonyl group.

Examples of the “unsubstituted or substituted C1 to C6 alkyl group” for R⁶ and R⁷ include the same groups as those exemplified above for R¹ and R⁴.

Examples of the “unsubstituted or substituted C1 to C6 alkylcarbonyl group”, “unsubstituted or substituted C1 to C6 alkoxycarbonyl group” and “unsubstituted or substituted C3 to C8 cycloalkyl group” for R⁶ and R⁷ include the same groups as those exemplified above for R³.

Examples of the “C3 to C8 cycloalkylcarbonyl group” for R⁶ and R⁷ include a cyclopropanecarbonyl group, cyclopentanecarbonyl group, and cyclohexanecarbonyl group.

Examples of the “C3 to C8 cycloalkoxycarbonyl group” for R⁶ and R⁷ include a cyclopropoxycarbonyl group, cyclopentyloxycarbonyl group, and cyclohexyloxycarbonyl group.

Examples of preferred substituents on the “C3 to C8 cycloalkylcarbonyl group” and “C3 to C8 cycloalkoxycarbonyl group” for R⁶ and R⁷ include halogeno groups such as a fluoro group, chloro group, bromo group, and iodo group; C1 to C6 alkyl groups such as a methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, and n-hexyl group; C1 to C6 haloalkyl groups such as a chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, and perfluoro-n-pentyl group; C1 to C6 alkoxy groups such as a methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, and t-butoxy group; C1 to C6 haloalkoxy groups such as a 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, and trifluoromethoxy group; and a cyano group.

Each of R⁶ and R⁷ is preferably a hydrogen atom or an unsubstituted or substituted C1 to C6 alkyl group (and preferably an unsubstituted C1 to C6 alkyl group), and is more preferably a hydrogen atom.

In formula (I), n indicates the number of divalent groups represented by CR⁸R⁹ shown inside the brackets, and is 0 or 1.

In formula (I), R⁸ and R⁹ each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group (and preferably an unsubstituted C1 to C6 alkyl group).

Examples of the “unsubstituted or substituted C1 to C6 alkyl group” for R⁸ and R⁹ include the same groups as those exemplified above for R¹ and R⁴.

In formula (I), Ar represents an unsubstituted or substituted C6 to C10 aryl group or an unsubstituted or substituted 5- or 6-membered heteroaryl group.

Examples of the “C6 to C10 aryl group” for Ar include the same groups as those exemplified above for R³.

Examples of the “5- or 6-membered heteroaryl group” for Ar include 5-membered heteroaryl groups such as a pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group (and specifically, a [1,2,3]-triazolyl group or [1,2,4]-triazolyl group), oxadiazolyl group (and specifically, a [1,2,3]-oxadiazolyl group, [1,2,4]-oxadiazolyl group, [1,2,5]-oxadiazolyl group or [1,3,4]-oxadiazolyl group), thiadiazolyl group, and tetrazolyl group; and 6-membered heteroaryl groups such as a pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, and triazinyl group.

Examples of preferred substituents on the “C6 to C10 aryl group” and “5- or 6-membered heteroaryl group” for Ar include halogeno groups such as a fluoro group, chloro group, bromo group, and iodo group; C1 to C6 alkyl groups such as a methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, and n-hexyl group; C1 to C6 haloalkyl groups such as a chloromethyl group, chloroethyl group, trifluoromethyl group, pentafluoroethyl group, 1,2-dichloro-n-propyl group, 1,1,1,3,3,3-hexafluoropropan-2-yl group, perfluoropropan-2-yl group, 1-fluoro-n-butyl group, and perfluoro-n-pentyl group; C1 to C6 alkoxy groups such as a methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, and t-butoxy group; C1 to C6 haloalkoxy groups such as a 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, and 2,2,2-trifluoroethoxy group; a carboxyl group; C1 to C6 alkylcarbonyl groups such as an acetyl group and propionyl group; C1 to C6 alkylcarbonylamino groups such as an acetylamino group, propanoylamino group, butyrylamino group, and i-propylcarbonylamino group; C1 to C6 alkoxycarbonyl groups such as a methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, and t-butoxycarbonyl group; C1 to C6 alkylaminocarbonyl groups such as a methylaminocarbonyl group, dimethylaminocarbonyl group, ethylaminocarbonyl group, and i-propylaminocarbonyl group; C1 to C6 haloalkylthio groups such as a trifluoromethylthio group; alkylsulfonyl groups such as a methylsulfonyl group; unsubstituted or C1 to C6 alkyl-substituted 5-membered heteroaryl groups such as a triazolyl group, oxadiazolyl group, pyrazolyl group, 3-methyl-1,2,4-oxazol-5-yl group, and 5-methyl-1,3,4-oxazol-5-yl group; a 4,5-dihydrooxazol-2-yl group; 6-membered heteroaryl groups such as a pyridyl group; C1 to C6 alkoxyimino C1 to C6 alkyl groups such as a methoxyiminomethyl group and (1-methoxyimino)ethyl group; a cyano group; a nitro group; and a pentafluorosulfanyl group.

Examples of particularly preferred substituents on the “C6 to C10 aryl group” and “5- or 6-membered heteroaryl group” for Ar include halogeno groups such as a fluoro group, chloro group, bromo group, and iodo group; C1 to C6 alkyl groups such as a methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, and n-hexyl group; C1 to C6 haloalkyl groups such as a chloromethyl group, chloroethyl group, trifluoromethyl group, pentafluoroethyl group, 1,2-dichloro-n-propyl group, 1,1,1,3,3,3-hexafluoropropan-2-yl group, perfluoropropan-2-yl group, 1-fluoro-n-butyl group, and perfluoro-n-pentyl group; C1 to C6 alkoxy groups such as a methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, and t-butoxy group; C1 to C6 haloalkoxy groups such as a 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, and 2,2,2-trifluoroethoxy group; a carboxyl group; C1 to C6 alkylcarbonyl groups such as an acetyl group and propionyl group; C1 to C6 alkoxycarbonyl groups such as a methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, and t-butoxycarbonyl group; unsubstituted or C1 to C6 alkyl-substituted 5-membered heteroaryl groups such as a triazolyl group, oxadiazolyl group, pyrazolyl group, 3-methyl-1,2,4-oxazol-5-yl group, and 5-methyl-1,3,4-oxazol-5-yl group; a 4,5-dihydrooxazol-2-yl group; 6-membered heteroaryl groups such as a pyridyl group; C1 to C6 alkoxyimino C1 to C6 alkyl groups such as a methoxyiminomethyl group and (1-methoxyimino)ethyl group; a cyano group; a nitro group; and a pentafluorosulfanyl group.

Ar is preferably an unsubstituted or substituted phenyl group, an unsubstituted or substituted thiazolyl group, or an unsubstituted or substituted pyridyl group, and is more preferably a substituted phenyl group, a substituted thiazolyl group, or a substituted pyridyl group.

There are no particular limitations on the salt of the compound (I), provided the salt is an agriculturally and horticulturally acceptable salt. Examples include salts of inorganic acids such as hydrochloric acid and sulfuric acid; salts of organic acids such as acetic acid and lactic acid; salts of alkali metals such as lithium, sodium and potassium; salts of alkaline earth metals such as calcium and magnesium; salts of transition metals such as iron and copper; and salts of organic bases such as ammonia, triethylamine, tributylamine, pyridine and hydrazine.

The compound (I) or the salt of the compound (I) is not particularly limited by the production method used. Further, the salt of the compound (I) can be obtained from the compound (I) by conventional methods. The compound (I) of the present invention or the salt of the compound (I) can be obtained by conventional production methods. Examples of the production method for the compound (I) of the present invention or the salt of the compound (I) include the methods described in the examples.

The sufonylaminobenzamide compound of the present invention has an excellent control effect on pests such as various agricultural pests, mites and nematodes that affect the growth of plants.

Further, because the sufonylaminobenzamide compound of the present invention causes no chemical damage to crops and exhibits low toxicity to fish and warm-blooded animals, it is a very safe compound. Accordingly, the compound is useful as an active constituent for insecticides, miticides and nematicides.

Moreover, in recent years, many insect pests such as Plutellidae, Delphacidae, Cicadellidae and Aphididae have developed resistance to various known chemical agents, causing problems of inadequate potency for these chemical agents, and there is much demand for a chemical agent that is also effective against these resistant strains. The sufonylaminobenzamide compound of the present invention exhibits an excellent control effect against insect pests, not only sensitive strains but also various resistant strains, and against mites of miticide-resistant strains.

Furthermore, the sufonylaminobenzamide compound of the present invention exhibits efficacy against all growth stages of the control target organisms, and for example exhibits a control effect on the eggs, nymphs, larvae, pupae and adults of mites, insects and nematodes.

[Pest Control Agent, Insecticide, Miticide, or Nematicide]

The pest control agent, or insecticide, miticide or nematicide, of the present invention contains at least one compound selected from the sufonylaminobenzamide compounds of the present invention as an active constituent. There are no particular limitations on the amount of the sufonylaminobenzamide compound of the present invention contained within the pest control agent, insecticide, miticide or nematicide of the present invention, provided a pest control effect is exhibited.

The pest control agent, or insecticide, miticide or nematicide, of the present invention is preferably used on plants such as grains; vegetables; root vegetables; tubers; flowers and ornamental plants; fruit trees; trees such as foliage plants, tea plants, coffee plants, and cacao plants; pasture grasses; lawn grasses; and cotton plants.

During application to the plant, the pest control agent, insecticide, miticide or nematicide of the present invention may be applied to any portion of the plant, including the leaves, stems, stalks, flowers, buds, fruit, seeds, sprouts, roots, tubers, tuberous roots, shoots or cuttings.

Furthermore, the pest control agent, or insecticide, miticide or nematicide, of the present invention is not particularly limited in terms of the types of plants on which it can be applied. Examples of the types of plants include original species, variants, improved varieties, cultivars, mutants, hybrids, and genetically modified species (GMO).

The pest control agent of the present invention can be used for a seed treatment, foliage application, soil application, or water surface application, for the purpose of controlling various agricultural pests, mites and nematodes.

Specific examples of the various agricultural pests, mites and nematodes that can be controlled by the pest control agent of the present invention are listed below.

(1) Lepidoptera Butterflies and Moths

(a) Arctiidae moths, for example, Hyphantria cunea and Lemyra imparilis;

(b) Bucculatricidae moths, for example, Bucculatrix pyrivorella;

(c) Carposinidae, for example, Carposina sasakii;

(d) Crambidae moths, for example, Diaphania indica and Diaphania nitidalis of Diaphania spp.; Ostrinia furnacalis, Ostrinia nubilalis and Ostrinia scapulalis of Ostrinia spp.; and others such as Chilo suppressalis, Cnaphalocrocis medinalis, Conogethes punctiferalis, Diatraea grandiosella, Glyphodes pyloalis, Hellula undalis and Parapediasia teterrella; (e) Gelechiidae moths, for example, Helcystogramma triannulella, Pectinophora gossypiella, Phthorimaea operculella and Sitotroga cerealella; (f) Geometridae moths, for example, Ascotis selenaria; (g) Gracillariidae moths, for example, Caloptilia theivora, Phyllocnistis citrella and Phyllonorycter ringoniella; (h) Hesperiidae butterflies, for example, Parnara guttata; (i) Lasiocampidae moths, for example, Malacosoma neustria; (j) Lymantriidae moths, for example, Lymantria dispar and Lymantria monacha of Lymantria spp.; and others such as Euproctis pseudoconspersa and Orgyia thyellina; (k) Lyonetiidae moths, for example, Lyonetia clerkella and Lyonetia prunifoliella malinella of Lyonetia spp.;(l) Noctuidae moths, for example, Spodoptera depravata, Spodoptera eridania, Spodoptera exigua, Spodoptera frugiperda, Spodoptera littoralis and Spodoptera litura of Spodoptera spp.; Autographa gamma and Autographa nigrisigna of Autographa spp.; Agrotis ipsilon and Agrotis segetum of Agrotis spp.; Helicoverpa armigera, Helicoverpa assulta and Helicoverpa zea of Helicoverpa spp.; Heliothis armigera and Heliothis virescens of Heliothis spp.; and others such as Aedia leucomelas, Ctenoplusia agnata, Eudocima tyrannus, Mamestra brassicae, Mythimna separata, Naranga aenescens, Panolis japonica, Peridroma saucia, Pseudoplusia includens and Trichoplusia ni; (m) Nolidae moths, for example, Earias insulana; (n) Pieridae butterflies, for example, Pieris brassicae and Pieris rapae crucivora of Pieris spp.;(o) Plutellidae moths, for example, Acrolepiopsis sapporensis and Acrolepiopsis suzukiella of Acrolepiopsis spp.; and others such as Plutella xylostella; (p) Pyralidae moths, for example, Cadra cautella, Elasmopalpus lignosellus, Etiella zinckenella and Galleria mellonella; (q) Sphingidae moths, for example, Manduca quinquemaculata and Manduca sexta of Manduca spp.;(r) Stathmopodidae moths, for example, Stathmopoda masinissa; (s) Tineidae moths, for example, Tinea translucens; (t) Tortricidae moths, for example, Adoxophyes honmai and Adoxophyes orana of Adoxophyes spp.; Archips breviplicanus and Archips fuscocupreanus of Archips spp.; and others such as Choristoneura fumiferana, Cydia pomonella, Eupoecilia ambiguella, Grapholitha molesta, Homona magnanima, Leguminivora glycinivorella, Lobesia botrana, Matsumuraeses phaseoli, Pandernis heparana and Sparganothis pilleriana; and(u) Yponomeutidae moths, for example, Argyresthia conjugella. (2) Thysanoptera Insect Pests(a) Phlaeothripidae, for example, Ponticulothrips diospyrosi; and(b) Thripidae, for example, Frankliniella intonsa and Frankliniella occidentalis of Frankliniella spp.; Thrips palmi and Thrips tabaci of Thrips spp.; and others such as Heliothrips haemorrhoidalis and Scirtothrips dorsalis. (3) Hemiptera Insect Pests(A) Archaeorrhyncha(a) Delphacidae, for example, Laodelphax striatella, Nilaparvata lugens, Perkinsiella saccharicida and Sogatella furcifera. (B) Clypeorrhyncha(a) Cicadellidae, for example, Empoasca fabae, Empoasca nipponica, Empoasca onukii and Empoasca sakaii of Empoasca spp.; and others such as Arboridia apicalis, Balclutha saltuella, Epiacanthus stramineus, Macrosteles striifrons and Nephotettix cinctinceps. (C) Heteroptera(a) Alydidae, for example, Riptortus clavatus; (b) Coreidae, for example, Cletus punctiger and Leptocorisa chinensis; (c) Lygaeidae, for example, Blissus leucopterus, Cavelerius saccharivorus and Togo hemipterus; (d) Miridae, for example, Halticus insularis, Lygus lineolaris, Psuedatomoscelis seriatus, Stenodema sibiricum, Stenotus rubrovittatus and Trigonotylus caelestialium; (e) Pentatomidae, for example, Nezara antennata and Nezara viridula of Nezara spp.; Eysarcoris aeneus, Eysarcoris lewisi and Eysarcoris ventralis of Eysarcoris spp.; and others such as Dolycoris baccarum, Eurydema rugosum, Glaucias subpunctatus, Halyomorpha halys, Piezodorus hybneri, Plautia crossota and Scotinophora lurida; (f) Pyrrhocoridae, for example, Dysdercus cingulatus; (g) Rhopalidae, for example, Rhopalus msculatus; (h) Scutelleridae, for example, Eurygaster integriceps; and(i) Tingidae, for example, Stephanitis nashi. (D) Sternorrhyncha(a) Adelgidae, for example, Adelges laricis; (b) Aleyrodidae, for example, Bemisia argentifolii and Bemisia tabaci of Bemisia spp.; and others such as Aleurocanthus spiniferus, Dialeurodes citri and Trialeurodes vaporariorum; (c) Aphididae, for example, Aphis craccivora, Aphis fabae, Aphis forbesi, Aphis gossypii, Aphis pomi, Aphis sambuci and Aphis spiraecola of Aphis spp.; Rhopalosiphum maidis and Rhopalosiphum padi of Rhopalosiphum spp.; Dysaphis plantaginea and Dysaphis radicola of Dysaphis spp.; Macrosiphum avenae and Macrosiphum euphorbiae of Macrosiphum spp.; Myzus cerasi, Myzus persicae and Myzus varians of Myzus spp.; and others such as Acyrthosiphon pisum, Aulacorthum solani, Brachycaudus helichrysi, Brevicoryne brassicae, Chaetosiphon fragaefolii, Hyalopterus pruni, Hyperomyzus lactucae, Lipaphis erysimi, Megoura viciae, Metopolophium dirhodum, Nasonovia ribis-nigri, Phorodon humuli, Schizaphis graminum, Sitobion avenae and Toxoptera aurantii; (d) Coccidae, for example, Ceroplastes ceriferus and Ceroplastes rubens of Ceroplastes spp.;(e) Diaspididae, for example, Pseudaulacaspis pentagona and Pseudaulacaspis prunicola of Pseudaulacaspis spp.; Unaspis euonymi and Unaspis yanonensis of Unaspis spp.; and others such as Aonidiella aurantii, Comstockaspis perniciosa, Fiorinia theae and Pseudaonidia paeoniae; (f) Margarodidae, for example, Drosicha corpulenta and Icerya purchasi; (g) Phylloxeridae, for example, Viteus vitifolii; (h) Pseudococcidae, for example, Planococcus citri and Planococcus kuraunhiae of Planococcus spp.; and others such as Phenacoccus solani and Pseudococcus comstocki; and(i) Psyllidae, for example, Psylla mali and Psylla pyrisuga of Psylla spp.; and others such as Diaphorina citri. (4) Polyphaga Insect Pests(a) Anobiidae, for example, Lasioderma serricorne; (b) Attelabidae, for example, Byctiscus betulae and Rhynchites heros; (c) Bostrichidae, for example, Lyctus brunneus; (d) Brentidae, for example, Cylas formicarius; (e) Buprestidae, for example, Agrilus sinuatus; (f) Cerambycidae, for example, Anoplophora malasiaca, Monochamus alternatus, Psacothea hilaris and Xylotrechus pyrrhoderus; (g) Chrysomelidae, for example, Bruchus pisorum and Bruchus rufimanus of Bruchus spp.; Diabrotica barberi, Diabrotica undecimpunctata and Diabrotica virgifera of Diabrotica spp.; Phyllotreta nemorum and Phyllotreta striolata of Phyllotreta spp.; and others such as Aulacophora femoralis, Callosobruchus chinensis, Cassida nebulosa, Chaetocnema concinna, Leptinotarsa decemlineata, Oulema oryzae and Psylliodes angusticollis; (h) Coccinellidae, for example, Epilachna varivestis and Epilachna vigintioctopunctata of Epilachna spp.;(i) Curculionidae, for example, Anthonomus grandis and Anthonomus pomorum of Anthonomus spp.; Sitophilus granarius of Sitophilus zeamais of Sitophilus spp.; and others such as Echinocnemus squameus, Euscepes postfasciatus, Hylobius abietis, Hypera postica, Lissohoptrus oryzophilus, Otiorhynchus sulcatus, Sitona lineatus and Sphenophorus venatus; (j) Elateridae, for example, Melanotus fortnumni and Melanotus tamsuyensis of Melanotus spp.;(k) Nitidulidae, for example, Epuraea domina; (L) Scarabaeidae, for example, Anomala cuprea and Anomala rufocuprea of Anomala spp.; and others such as Cetonia aurata, Gametis jucunda, Heptophylla picea, Melolontha melolontha and Popillia japonica; (m) Scolytidae, for example, Ips typographus; (n) Staphylinidae, for example, Paederus fuscipes; (o) Tenebrionidae, for example, Tenebrio molitor and Tribolium castaneum; and(p) Trogossitidae, for example, Tenebroides mauritanicus. (5) Diptera Insect Pests(A) Brachycera(a) Agromyzidae, for example, Liriomyza bryoniae, Liriomyza chinensis, Liriomyza sativae and Liriomyza trifolii of Liriomyza spp.; and others such as Chromatomyia horticola and Agromyza oryzae; (b) Anthomyiidae, for example, Delia platura and Delia radicum of Delia spp.; and others such as Pegomya cunicularia; (c) Drosophilidae, for example, Drosophila melanogaster and Drosophila suzukii of Drosophila spp.;(d) Ephydridae, for example, Hydrellia griseola; (e) Psilidae, for example, Psila rosae; and(f) Tephritidae, for example, Bactrocera cucurbitae and Bactrocera dorsalis of Bactrocera spp.; Rhagoletis cerasi and Rhagoletis pomonella of Rhagoletis spp.; and others such as Ceratitis capitata and Dacus oleae. (B) Nematocera(a) Cecidomyiidae, for example, Asphondylia yushimai, Contarinia sorghicola, Mayetiola destructor and Sitodiplosis mosellana. (6) Orthoptera Insect Pests(a) Acrididae, for example, Schistocerca americana and Schistocerca gregaria of Schistocerca spp.; and others such as Chortoicetes terminifera, Dociostaurus maroccanus, Locusta migratoria, Locustana pardalina, Nomadacris septemfasciata and Oxya yezoensis; (b) Gryllidae, for example, Acheta domestica and Teleogryllus emma; (c) Gryllotalpidae, for example, Gryllotalpa orientalis; and(d) Tettigoniidae, for example, Tachycines asynamorus. (7) Acari(A) Acaridida of Astigmata(a) Acaridae mites, for example, Rhizoglyphus echinopus and Rhizoglyphus robini of Rhizoglyphus spp.; Tyrophagus neiswanderi, Tyrophagus perniciosus, Tyrophagus putrescentiae and Tyrophagus similis of Tyrophagus spp.; and others such as Acarus siro, Aleuroglyphus ovatus and Mycetoglyphus fungivorus; (B) Actinedida of Prostigmata(a) Tetranychidae mites, for example, Bryobia praetiosa and Bryobia rubrioculus of Bryobia spp.; Eotetranychus asiaticus, Eotetranychus boreus, Eotetranychus celtis, Eotetranychus geniculatus, Eotetranychus kankitus, Eotetranychus pruni, Eotetranychus shii, Eotetranychus smithi, Eotetranychus suginamensis and Eotetranychus uncatus of Eotetranychus spp.; Oligonychus hondoensis, Oligonychus ilicis, Oligonychus karamatus, Oligonychus mangiferus, Oligonychus orthius, Oligonychus perseae, Oligonychus pustulosus, Oligonychus shinkajii and Oligonychus ununguis of Oligonychus spp.; Panonychus citri, Panonychus mori and Panonychus ulmi of Panonychus spp.; Tetranychus cinnabarinus, Tetranychus kanzawai, Tetranychus ludeni, Tetranychus quercivorus, Tetranychus phaselus, Tetranychus urticae and Tetranychus viennensis of Tetranychus spp.; Aponychus corpuzae and Aponychus firmianae of Aponychus spp.; Sasanychus akitanus and Sasanychus pusillus of Sasanychus spp.; Shizotetranychus celarius, Shizotetranychus longus, Shizotetranychus miscanthi, Shizotetranychus recki and Shizotetranychus schizopus of Shizotetranychus spp.; and others such as Tetranychina harti, Tuckerella pavoniformis and Yezonychus sapporensis; (b) Tenuipalpidae mites, for example, Brevipalpus lewisi, Brevipalpus obovatus, Brevipalpus phoenicis, Brevipalpus russulus and Brevipalpus californicus of Brevipalpus spp.; Tenuipalpus pacificus and Tenuipalpus zhizhilashviliae of Tenuipalpus spp.; and others such as Dolichotetranychus floridanus; (c) Eriophyidae mites, for example, Aceria diospyri, Aceria ficus, Aceria japonica, Aceria kuko, Aceria paradianthi, Aceria tiyingi, Aceria tulipae and Aceria zoysiea of Aceria spp.; Eriophyes chibaensis and Eriophyes emarginatae of Eriophyes spp.; Aculops lycopersici and Aculops pelekassi of Aculops spp.; Aculus fockeui and Aculus schlechtendali of Aculus spp.; and others such as Acaphylla theavagrans, Calacarus carinatus, Colomerus vitis, Calepitrimerus vitis, Epitrimerus pyri, Paraphytoptus kikus, Paracalacarus podocarpi and Phyllocotruta citri; (d) Transonemidae mites, for example, Tarsonemus bilobatus and Tarsonemus waitei of Tarsonemus spp.; and others such as Phytonemus pallidus and Polyphagotarsonemus latus; and(e) Penthaleidae mites, for example, Penthaleus erythrocephalus and Penthaleus major of Penthaleus spp.(8) Phytoparasitic Nematodes(A) Tylenchida(a) Anguinidae, for example, Anguina funesta and Anguina tritici of Anguina spp.; and Ditylenchus destructor, Ditylenchus dipsaci and Ditylenchus myceliophagus of Ditylenchus spp.;(b) Aphelenchoididae, for example, Aphelenchoides besseyi, Aphelenchoides fragariae, Aphelenchoides ritzemabosi and Aphelenchoides besseyi of Aphelenchoides spp.; and Bursaphelenchus xylophilus of Bursaphelenchus spp.;(c) Belonolaimidae, for example, Belonolaimus longicaudatus of Belonolaimus spp.; and Tylenchorhynchus claytoni and Tylenchorhynchus dubius of Tylenchorhynchus spp.;(d) Criconematidae, for example, Criconema mutabile; (e) Dolichodoridae, for example, Dolichodorus mediterraneus; (f) Ecphyadophoridae, for example, Ecphyadophora tenuissima; (g) Hemicycliophoridae, for example, Loofia thienemanni (h) Heteroderidae, for example, Globodera rostochiensis, Globodera pallida and Globodera tabacum of Globodera spp.; and Heterodera avenae, Heterodera cruciferae, Heterodera glycines, Heterodera schachtii and Heterodera trifolii of Heterodera spp.;(i) Hoplolaimidae, for example, Helicotylenchus dihystera and Helicotylenchus multicinctus of Helicotylenchus spp.; Hoplolaimus columbus and Hoplolaimus galeatus of Hoplolaimus spp.; and others such as Rotylenchus robustus and Rotylenchulus reniformis; (j) Meloidogynidae, for example, Meloidogyne arenaria, Meloidogyne chitwoodi, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica and Meloidogyne thamesi of Meloidogyne spp.;(k) Nothotylenchidae, for example, Nothotylenchus acris; (l) Paratylenchidae, for example, Paratylenchus curvitatus and Paratylenchus elachistus of Paratylenchus spp.; and(m) Pratylenchidae, for example, Pratylenchus brachyurus, Pratylenchus coffeae, Pratylenchus curvitatus, Pratylenchus fallax, Pratylenchus goodeyi, Pratylencus neglectus, Pratylenchus penetrans, Pratylenchus scribneri, Pratylenchus vulnus and Pratylenchus zeae of Pratylenchus spp.; and others such as Nacobbus aberrans, Radopholus similis, Tylenchulus semnipenetrans and Radopholus citrophilus. (B) Dorylaimida(a) Longidoridae, for example, Longidorus elongates of Longidorus spp.; and Xiphinema americanum, Xiphinema brevicolle, Xiphinema index and Xiphinema diversicaudatum of Xiphinema spp.(C) Triplonchida(a) Trichodoridae, for example, Trichodorus primitivus and Paratrichodorus minor.

The pest control agent of the present invention may be mixed or used in combination with other active constituents such as fungicides, insecticides and miticides, nematicides and soil pesticides; and/or plant regulators, herbicides, synergists, fertilizers, soil conditioners and animal feed.

Combinations of the compound of the present invention with other active constituents can be expected to provide synergistic effects in terms of insecticide, miticide and nematicide activity. This type of synergistic effect can be confirmed using the Colby equation in accordance with typical methods (Colby, S. R.; Calculating Synergistic and Antagonistic Responses of Herbicide Combinations; Weeds 15, pp. 20 to 22, 1967).

Specific examples of insecticides, miticides, nematicides, soil pesticides, and parasiticides and the like that can be mixed or used in combination with the pest control agent of the present invention are listed below.

(1) Acetylcholinesterase inhibitors:

(a) Carbamate-based: alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC, xylycarb; fenothiocarb, MIPC, MPMC, MTMC, aldoxycarb, allyxycarb, aminocarb, bufencarb, cloethocarb, metam-sodium, and promecarb; and(2) Organophosphorus-based: acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate, dimethylvinfos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isocarbophos, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridafenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon, vamidothion; bromophos-ethyl, BRP, carbophenothion, cyanofenphos, CYAP, demeton-S-methyl sulfone, dialifos, dichlofenthion, dioxabenzofos, etrimfos, fensulfothion, flupyrazofos, fonofos, formothion, fosmethilan, isazophos, iodofenphos, methacrifos, pirimiphos-ethyl, phosphocarb, propaphos, prothoate, and sulprofos.(2) GABA receptor chloride ion channel antagonists: acetoprole, chlordane, endosulfan, ethiprole, fipronil, pyrafluprole, pyriprole; camphechlor, heptachlor, and dienochlor.(3) Sodium channel modulators: acrinathrin, d-cis/trans-allethrin, d-trans-allethrin, bifenthrin, bioallethrin, bioallethrin S-cyclopentyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans isomer], delta-methrin, empenthrin [(EZ)-(1R)-isomer], esfenvalerate, ethofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, permethrin, phenothrin [(1R)-trans isomer], prallethrin, pyrethrum, resmethrin, silafluofen, tefluthrin, tetramethrin [(1R)-isomer], tralomethrin, transfluthrin; allethrin, pyrethrin, pyrethrin I, pyrethrin II, profluthrin, dimefluthrin, bioethanomethrin, biopermethrin, transpermethirn, fenfluthrin, fenpyrithrin, flubrocythrinate, flufenoprox, metofluthrin, protrifenbute, pyresmethrin, and terallethrin.(4) Nicotinic acetylcholine receptor agonists: acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid, thiamethoxam, sulfoxaflor, nicotine, and flupyradifurone.(5) Nicotinic acetylcholine receptor allosteric modulators: spinetoram and spinosad.(6) Chloride channel activators: abamectin, emamectin-benzoate, lepimectin, milbemectin; ivermectin, seramectin, doramectin, eprinomectin, moxidectin; milbemycin, milbemycin oxime, and nemadectin.(7) Juvenile hormone-like substances: hydroprene, kinoprene, methoprene, fenoxycarb, pyriproxyfen; diofenolan, epofenonane, and triprene.(8) Other nonspecific inhibitors: methyl bromide, chloropicrin, sulfuryl fluoride, borax, and tartar emetic.(9) Homoptera selective feeding inhibitors: flonicamid, pymetrozine, and pyrifluquinazon.(10) Mite growth inhibitors: clofentezine, diflovidazin, hexythiazox, and etoxazole.(11) Microorganism-derived insect midgut inner membrane disrupting agents: Bacillus thuringiensis subsp. israelensis, Bacillus sphaericus, Bacillus thuringiensis subsp. aizawai, Bacillus thuringiensis subsp. kurstaki, Bacillus thuringiensis subsp. tenebrionis, Bt crop protein: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Abl/Cry35Abl.(12) Mitochondria ATP biosynthesis enzyme inhibitors: diafenthiuron, azocyclotin, cyhexatin, fenbutatin oxide, propargite, and tetradifon.(13) Oxidative phosphorylation uncoupling agents: chlorfenapyr, sulfluramid, DNOC; binapacryl, dinobuton, and dinocap.(14) Nicotinic acetylcholine receptor channel blockers: bensultap, cartap hydrochloride; nereistoxin; thiosultap-sodium, and thiocyclarm.(15) Chitin synthesis inhibitors: bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, novifumuron, teflubenzuron, triflumuron, buprofezin, and fluazuron.(16) Diptera molting disturbing agent: cyromazine.(17) Molting hormone receptor agonists: chromafenozide, halofenozide, methoxyfenozide, and tebufenozide.(18) Octopamine receptor agonists: amitraz, demiditraz, and chlordimeform(19) Mitochondria electron transfer chain complex III inhibitors: acequinocyl, fluacrypyrim, and hydramethylnon.(20) Mitochondria electron transfer chain complex I inhibitors: fenazaquin, fenproximate, pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad, and rotenone.(21) Voltage-dependent sodium channel blockers: indoxacarb and metaflumizone.(22) Acetyl CoA carboxylase inhibitors: spirodiclofen, spiromesifen, and spirotetramat.(23) Mitochondria electron transfer chain complex IV inhibitors: aluminium phosphide, calcium phosphide, phosphine, zinc phosphide, and cyanide.(24) Mitochondria electron transfer chain complex II inhibitors: cyenopyrafen, cyflumetofen, and pyflubumide.(25) Ryanodine receptor modulators: chlorantraniliprole, cyantraniliprole, flubendiamide, cyclaniliprole, and tetraniliprole.(26) Mixed function oxidase inhibitor compound: piperonyl butoxide.(27) Latrophilin receptor agonists: depsipeptide, cyclodepsipeptide, 24-membered cyclodepsipeptide, emodepside.(28) Others (for which the mode of action is unknown): azadirachtin, benzoximate, bifenazate, bromopropylate, quinomethionate, cryolite, dicofol, pyridalyl; benclothiaz, sulfur, amidoflumet, 1,3-dichloropropene, DCIP, phenisobromolate, benzomate, metaldehyde, chlorobenzilate, chlothiazoben, dicyclanil, fenoxacrim, fentrifanil, flubenzimine, fluphenazine, gossyplure, japonilure, metoxadiazone, oil, potassium oleate, tetrasul, triarathene; afidopyropen, flometoquin, flufiprole, fluensulfone, meperfluthrin, tetramethylfluthrin, tralopyril, dimefluthrin, methylneodecanamide; fluralaner, afoxolaner, fluxametamide,5-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile (CAS:943137-49-3), broflanilide, and other meta-diamides.(29) Parasiticides:(a) Benzimidazole-based: fenbendazole, albendazole, triclabendazole, oxibendazole, mebendazole, oxfendazole, parbendazole, flubendazole; febantel, netobimin, thiophanate; thiabendazole, and cambendazole;(b) Salicylanilide-based: closantel, oxyclozanide, rafoxanide, and niclosamide;(c) Substituted phenol-based: nitroxinil, nitroscanate;(d) Pyrimidine-based: pyrantel and morantel;(e) Imidazothiazole-based: levamisole and tetramisole;(f) Tetrahydropyrimidine-based: praziquantel and epsiprantel; and(g) Other parasiticides: cyclodiene, ryania, clorsulon, metronidazole, demiditraz; piperazine, diethylcarbamazine, dichlorophen, monepantel, tribendimidine, amidantel; thiacetarsamide, melarsomine, and arsenamide.

Specific examples of fungicides that can be mixed or used in combination with the pest control agent of the present invention are listed below.

(1) Nucleic acid biosynthesis inhibitors:

(a) RNA polymerase I inhibitors: benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M, oxadixyl; clozylacon, and ofurace;

(b) Adenosine deaminase inhibitors: bupirimate, dimethirimol, and ethirimol;

(c) DNA/RNA synthesis inhibitors: hymexazol and octhilinone; and

(d) DNA topoisomerase II inhibitor: oxolinic acid.

(2) Mitotic inhibitors and cell division inhibitors:

(a) β-tubulin polymerization inhibitors: benomyl, carbendazim, chlorfenazole, fuberidazole, thiabendazole; thiophanate, thiophanate-methyl; diethofencarb; zoxamide; and ethaboxam;

(b) Cell division inhibitor: pencycuron; and

(c) Delocalization inhibitor of spectrin-like proteins: fluopicolide.

(3) Respiration inhibitors:

(a) Complex I NADH oxidoreductase inhibitors: diflumetorim and tolfenpyrad;

(b) Complex II succinic acid dehydrogenase inhibitors: benodanil, flutolanil, mepronil; isofetamid, fluopyram; fenfuram, furmecyclox; carboxin, oxycarboxin; thifluzamide; benzovindiflupyr, bixafen, fluxapyroxad, furametpyr, isopyrazam, penflufen, penthiopyrad, sedaxane; and boscalid;(c) Complex III ubiquinol oxidase Qo inhibitors: azoxystrobin, coumoxystrobin, coumethoxystrobin, enoxastrobin, flufenoxystrobin, picoxystrobin, pyraoxystrobin; pyraclostrobin, pyrametostrobin, triclopyricarb; kresoxim-methyl, trifloxystrobin; dimoxystrobin, fenaminstrobin, metominostrobin, orysastrobin; famoxadone; fluoxastrobin; fenamidone; and pyribencarb;(d) Complex III ubiquinol reductase Qi inhibitors: cyazofamid and amisulbrom;(e) Oxidative phosphorylation uncoupling agents: binapacryl, meptyldinocap, dinocap; fluazinam; and ferimzone;(f) Oxidative phosphorylation inhibitors (ATP synthase inhibitors): fentin acetate, fentin chloride, and fentin hydroxide;(g) ATP production inhibitor: silthiofam; and(h) Complex III cytochrome bcl (ubiquinone reductase) Qx (unknown) inhibitor: ametoctradin;(4) Amino acid and protein synthesis inhibitors(a) Methionine biosynthesis inhibitors: andoprim, cyprodinil, mepanipyrim, and pyrimethanil; and(b) Protein synthesis inhibitors: blasticidin-S; kasugamycin; kasugamycin hydrochloride; streptomycin; and oxytetracycline.(5) Signal transduction inhibitors:(a) Signal transduction inhibitors: quinoxyfen and proquinazid; and(b) MAP/histidine kinase inhibitors in osmotic pressure signal transduction: fenpiclonil, fludioxonil; chlozolinate, iprodione, procymidone, and vinclozolin.(6) Lipid and cell membrane synthesis inhibitors:(a) Phospholipid biosynthesis and methyltransferase inhibitors: edifenphos, iprobenfos, pyrazophos; and isoprothiolane;(b) Lipid peroxidation agents: biphenyl, chloroneb, dichloran, quintozene, tecnazene, tolclofos-methyl; and etridiazole;(c) Agents that act upon cell membranes: iodocarb, propamocarb, propamocarb-hydrochloride, propamocarb-fosetylate, and prothiocarb;(d) Microorganisms that disturb pathogen cell membranes: Bacillus subtilis, Bacillus subtilis strain QST713, Bacillus subtilis strain FZB24, Bacillus subtilis strain MBI600, and Bacillus subtilis strain D747; and(e) Agents that disturb cell membranes: Melaleuca alternifolia (tea tree) extract.(7) Cell membrane sterol biosynthesis inhibitors:(a) C14 position demethylation inhibitors in sterol biosynthesis: triforine; pyrifenox, pyrisoxazole; fenarimol, flurprimidol, nuarimol; imazalil, imazalil-sulfate, oxpoconazole, pefurazoate, prochloraz, triflumizole, viniconazole; azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazol, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, furconazole, furconazole-cis, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, quinconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole; prothioconazole, and voriconazole;(b) Δ14 reductase and Δ8→Δ7-isomerase inhibitors in sterol biosynthesis: aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph; fenpropidin, piperalin; and spiroxamine;(c) 3-keto reductase inhibitors in C4-position demethylation in sterol biosynthesis systems: fenhexamid and fenpyrazamine; and(d) Squalene epoxidase inhibitors in sterol biosynthesis systems: pyributicarb; naftifene, and terbinafine.(8) Cell wall synthesis inhibitors:(a) Trehalase inhibitor: validamycin;(b) Chitin synthase inhibitors: polyoxins and polyoxorim; and(c) Cellulose synthase inhibitors: dimethomorph, flumorph, pyrimorph; benthiavalicarb, iprovalicarb, tolprocarb, valifenalate; and mandipropamide.(9) Melanin biosynthesis inhibitors:(a) Reductase inhibitors in melanin biosynthesis: fthalide; pyroquilon; and tricyclazole; and(b) Anhydrase inhibitors in melanin biosynthesis: carpropamid; diclocymet; and fenoxanil.(10) Host plant resistance-inducing agents:(a) Agent that acts on salicylic acid biosynthetic pathway: acibenzolar-S-methyl; and(b) Others: probenazole; tiadinil; isotianil; laminarin; and Reynoutria sachalinensis extract.(11) Agents for which the mode of activity is unclear: cymoxanil, fosetyl-aluminum, phosphoric acid (phosphate), tecloftalam, triazoxide, flusulfamide, diclomezine, methasulfocarb, cyflufenamid, metrafenone, pyriofenone, dodine, dodine free base, and flutianil.(12) Agents having multiple activities: copper (copper salts), bordeaux mixture, copper hydroxide, copper naphthalate, copper oxide, copper oxychloride, copper sulfate, sulfur, sulfur products, calcium polysulfide; ferbam, mancozeb, maneb, mancopper, metiram, polycarbamate, propineb, thiram, zineb, ziram; captan, captafol, folpet; chlorothalonil; dichlofluanid, tolylfluanid; guazatine, iminoctadine triacetate, iminoctadine trialbesilate; anilazine; dithianon; quinomethionate; and fluoroimide.(13) Other agents: DBEDC, fluorofolpet, guazatine acetate, bis(8-quinolinolato) copper(II), propamidine, chloropicrin, cyprofuram, agrobacterium, bethoxazin, diphenylamine, methyl isothiocyanate (MITC), mildiomycin, capsaicin, curfraneb, cyprosulfamide, dazomet, debacarb, dichlorophen, difenzoquat, difenzoquat methyl sulfonate, flumetover, fosetyl-calcium, fosetyl-sodium, irumamycin, natamycin, nitrothal-isopropyl, oxamocarb, puropamocin sodium, pyrrolnitrin, tebufloquin, tolnifanide, zarilamide, Algophase, Amicarthiazol, Oxathiapiprolin, metiram-zinc, benthiazole, trichlamide, uniconazole, mildiomycin, Oxyfenthiin, and picarbutrazox.

Specific examples of plant growth regulators that can be mixed or used in combination with the pest control agent of the present invention are listed below.

Abscisic acid, kinetin, benzylaminopurine, 1,3-diphenylurea, forchlorfenuron, thidiazuron, chlorfenuron, dihydrozeatin, gibberellin A, gibberellin A4, gibberellin A7, gibberellin A3, 1-methylcyclopropane, N-acetyl aminoethoxyvinylglycine (alternative name: aviglycine), aminooxyacetate, silver nitrate, cobalt chloride, IAA, 4-CPA, cloprop, 2,4-D, MCPB, indole-3-butyric acid, dichlorprop, phenothiol, 1-naphthylacetamide, ethychlozate, cloxyfonac, maleic acid hydrazide, 2,3,5-triiodobenzoic acid, salicylic acid, methyl salicylate, (−)-jasmonic acid, methyl jasmonate, (+)-strigol, (+)-deoxystrigol, (+)-orobanchol, (+)-sorgolactone, 4-oxo-4-(2-phenylethyl)aminobutyric acid; ethephon, chlormequat, mepiquat chloride, benzyl adenine, and 5-aminolevulinic acid.

[Endoparasite Control Agent or Parasiticide]

An endoparasite control agent or parasiticide of the present invention contains at least one compound selected from the sufonylaminobenzamide compounds of the present invention as an active constituent.

The parasites targeted by the endoparasite control agent or parasiticide of the present invention live inside the bodies of host animals, and particularly inside the bodies of warm-blooded animals and fish (namely, endoparasites). Examples of host animals for which the endoparasite control agent or parasiticide of the present invention is effective include warm-blooded animals such as humans, domestic mammals (for example, cows, horses, pigs, sheep, and goats and the like), experimental animals (for example, mice, rats, and gerbils and the like), pet animals (for example, hamsters, guinea pigs, dogs, cats, horses, squirrels, rabbits, and ferrets and the like), wild mammals and zoo mammals (for example, monkeys, foxes, deer, and buffalo and the like), domestic fowl (for example, turkeys, ducks, chickens, and quail and the like), pet birds (for example, pigeons, parrots, myna birds, Java finches, parakeets, Bengalese finches, and canaries and the like); and fishes such as salmon, trout, and koi carp and the like. By controlling or exterminating the parasites, parasitic diseases carried by the parasites can be prevented or treated.

Examples of parasites that can be controlled or exterminated include those listed below.

(1) Dioctophymatida nematodes

(a) Kidney worms of the Dioctophymatidae family, for example, Dioctophyma renale of Dioctophyma spp.; and

(b) Kidney worms of the Soboliphymlatidae family, for example, Soboliphyme abei and Soboliphyme baturini of Soboliphyme spp.

(2) Trichocephalida nematodes

(a) Trichina worms of the Trichinellidae family, for example, Trichinella spiralis of Trichinella spp.; and

(b) Whipworms of the Trichuridae family, for example, Capillaria annulata, Capillaria contorta, Capillaria hepatica, Capillaria perforans, Capillaria plica and Capillaria suis of Capillaria spp.; and Trichuris vulpis, Trichuris discolor, Trichuris ovis, Trichuris skrjabini and Trichuris suis of Trichuris spp.(3) Rhabditida nematodes

Threadworms of the Strongyloididae family, for example, Strongyloides papillosus, Strongyloides planiceps, Strongyloides ransomi, Strongyloides suis, Strongyloides stercoralis, Strongyloides tumefaciens and Strongyloides ratti of Strongyloides spp.

(4) Strongylida nematodes

Hookworms of the Ancylostomatidae family, for example, Ancylostoma braziliense, Ancylostoma caninum, Ancylostoma duodenale and Ancylostoma tubaeforme of Ancylostoma spp.; Uncinaria stenocephala of Uncinaria spp.; and Bunostomum phlebotounm and Bunostomum trigonocephalum of Bunostomum spp.

(5) Strongylida nematodes

(a) Nematodes of the Angiostrongylidae family, for example, Aelurostrongylus abstrusus of Aelurostrongylus spp.; and Angiostrongylus vasorum and Angiostrongylus cantonesis of Angiostrongylus spp.;

(b) Nematodes of the Crenosomatidae family, for example, Crenosoma aerophila and Crenosoma vulpis of Crenosoma spp.;

(c) Nematodes of the Filaroididae family, for example, Filaroides hirthi and Filaroides osleri of Filaroides spp.;

(d) Lungworms of the Metastrongylidae family, for example, Metastrongylus apri, Metastrongylus asymmetricus, Metastrongylus pudendotectus and Metastrongylus salmi of Metastrongylus spp.; and

(e) Gapeworms of the Syngamidae family, for example, Cyathostoma bronchialis of Cyathostoma spp.; and Syngamus skrjabinomorpha and Syngamus trachea of Syngamus spp.

(6) Strongylida nematodes

(a) Nematodes of the Molineidae family, for example, Nematodirus filicollis and Nematodirus spathiger of Nematodirus spp.;

(b) Nematodes of the Dictyocaulidae family, for example, Dictyocaulus filarial and Dictyocaulus viviparus of Dictyocaulus spp.;

(c) Nematodes of the Haemonchidae family, for example, Haemonchus contortus of Haemonchus spp.; and Mecistocirrus digitatus of Mecistocirrus spp.; (d) Nematodes of the Haemonchidae family, for example, Ostertagia ostertagi of Ostertagia spp.;

(e) Nematodes of the Heligmonellidae family, for example, Nippostrongylus braziliensis of Nippostrongylus spp.; and

(f) Nematodes of the Trichostrongylidae family, for example, Trichostrongylus axei, Trichostrongylus colubriformis and Trichostrongylus tenuis of Trichostrongylus spp.; Hyostrongylus rubidus of Hyostrongylus spp.; and Obeliscoides cuniculi of Obeliscoides spp.(7) Strongylida nematodes(a) Nematodes of the Chabertiidae family, for example, Chabertia ovina of Chabertia spp.; and Oesophagostomum brevicaudatum, Oesophagostomum columbianum, Oesophagostomum dentatum, Oesophagostomum georgianum, Oesophagostomum maplestonei, Oesophagostomum quadrispinulatum, Oesophagostomum radiatum, Oesophagostomum venulosum and Oesophagostomum watanabei of Oesophagostomum spp.;(b) Nematodes of the Stephanuridae family, for example, Stephanurus dentatus of Stephanurus spp.; and(c) Nematodes of the Strongylidae family, for example, Strongylus asini, Strongylus edentatus, Strongylus equinus and Strongylus vulgaris of Strongylus spp.(8) Oxyurida nematodes

Nematodes of the Oxyuridae family, for example, Enterobius anthropopitheci and Enterobius vermicularis of Enterobius spp.; Oxyuris equi of Oxyuris spp.; and Passalurus ambiguus of Passalurus spp.

(9) Ascaridida nemtaodes

(a) Nematodes of the Ascaridiidae family, for example, Ascaridia galli of Ascaridia spp.;

(b) Nematodes of the Heterakidae family, for example, Heterakis beramporia, Heterakis brevispiculum, Heterakis gallinarum, Heterakis pusilla and Heterakis putaustralis of Heterakis spp.;

(c) Nematodes of the Anisakidae family, for example, Anisakis simplex of Anisakis spp.;

(d) Nematodes of the Ascarididae family, for example, Ascaris lumnbricoides and Ascaris suum of Ascaris spp.; and Parascaris equorum of Parascaris spp.; and

(e) Nematodes of the Toxocaridae family, for example, Toxocara canis, Toxocara leonina, Toxocarasuum, Toxocara vitulorum and Toxocara cati of Toxocara spp.

(10) Spirurida nematodes

(a) Nematodes of the Onchocercidae family, for example, Brugia malayi, Brugia pahangi and Brugia patei of Brugia spp.; Dipetalonema reconditum of Dipetalonema spp.; Dirofilaria immitis of Dirofilaria spp.; Filaria oculi of Filaria spp.; and Onchocerca cervicalis, Onchocerca gibsoni and Onchocerca gutturosa of Onchocerca spp.(b) Nematodes of the Setariidae family, for example, Setaria digitata, Setaria equina, Setaria labiatopapillosa and Setaria marshalli of Setaria spp.; and Wuchereria bancrofti of Wuchereria spp.; and(c) Nematodes of the Filariidae family, for example, Parafilaria multipapillosa of Parafilaria spp.; and Stephanofilaria assamensis, Stephanofilaria dedoesi, Stephanofilaria kaeli, Stephanofilaria okinawaensis and Stephanofilaria stilesi of Stephanofilaria spp.(11) Spirurida nematodes(a) Nematodes of the Gnathostomatidae family, for example, Gnathostoma doloresi and Gnathostoma spinigerum of Gnathostoma spp.;(b) Nematodes of the Habronematidae family, for example, Habronema majus, Habronema microstoma and Habronema muscae of Habronema spp.; and Draschia megastoma of Draschia spp.;(c) Nematodes of the Physalopteridae family, for example, Physaloptera canis, Physaloptera cesticillata, Physaloptera erdocyona, Physaloptera felidis, Physaloptera gemina, Physaloptera papilloradiata, Physaloptera praeputialis, Physaloptera pseudopraerutialis, Physaloptera rara, Physaloptera sibirica and Physaloptera vulpineus of Physaloptera spp.;(d) Nematodes of the Gongylonematidae family, for example, Gongylonema pulchrum of Gongylonema spp.;(e) Nematodes of the Spirocercidae family, for example, Ascarops strongylina of Ascarops spp.; and(f) Nematodes of the Thelaziidae family, for example, Thelazia callipaeda, Thelazia gulosa, Thelazia lacrymalis, Thelazia rhodesi and Thelazia skrjabini of Thelazia spp.[Control Agent for Other Pests]

In addition, the pest control agent of the present invention exhibits an excellent control effect on other pests that have a sting or venom that can harm humans and animals, pests carrying various pathogens and pathogenic bacteria, and pests that impart discomfort to humans (such as toxic pests, sanitary insect pests, unpleasant insect pests).

Specific examples of these other pests are listed below.

(1) Hymenoptera insect pests

Sawflies of the Argidae family, wasps of the Cynipidae family, sawflies of the Diprionidae family, ants of the Formicidae family, wasps of the Mutillidae vamily family, and wasps of the Vespidae family.

(2) Other insect pests

Blattodea, termites, Araneae, centipedes, millipedes, crustacea and Cimex lectularius.

EXAMPLES

[Formulations]

Several examples of formulations of the pest control agent, insecticide, miticide, nematicide, endoparasite control agent or parasiticide of the present invention are described below, but the additives and the addition ratios are not limited to those detailed in these examples, and can be modified over a wide range. The units “parts” in the formulations indicate “parts by weight”.

Formulations for agricultural and horticultural use and formulations for paddy rice are described below.

(Formulation 1: Water-Dispersible Powder)

Forty parts of the sufonylaminobenzamide compound of the present invention, 53 parts of diatomaceous earth, 4 parts of a higher alcohol sulfate and 3 parts of an alkylnaphthalene sulfonate salt were mixed together uniformly and then finely crushed to obtain a water-dispersible powder containing 40% of the active constituent.

(Formulation 2: Emulsion)

Thirty parts of the sufonylaminobenzamide compound of the present invention, 33 parts of xylene, 30 parts of dimethylformamide and 7 parts of a polyoxyethylene alkyl aryl ether were mixed together and dissolved to obtain an emulsion containing 30% of the active constituent.

(Formulation 3: Granules)

Five parts of the sufonylamninobenzamide compound of the present invention, 40 parts of talc, 38 parts of clay, 10 parts of bentonite and 7 parts of sodium alkyl sulfate were mixed together uniformly and then finely crushed, and the resulting powder was granulated into a granular shape having a diameter of 0.5 to 1.0 mm to obtain granules containing 5% of the active constituent.

(Formulation 4: Granules)

Five parts of the sufonylaminobenzamide compound of the present invention, 73 parts of clay, 20 parts of bentonite, 1 part of sodium dioctylsulfosuccinate and 1 part of potassium phosphate were thoroughly crushed and mixed together, water was then added to the resulting powder and thoroughly mixed, and the mixture was granulated and dried to obtain granules containing 5% of the active constituent.

(Formulation 5: Suspension)

Ten parts of the sufonylaminobenzamide compound of the present invention, 4 parts of a polyoxyethylene alkyl aryl ether, 2 parts of sodium polycarboxylate, 10 parts of glycerol, 0.2 parts of xanthan gum and 73.8 parts of water were mixed, and the resulting mixture was subjected to wet crushing down to a grain size of not more than 3 microns to obtain a suspension containing 10% of the active constituent.

Formulations for endoparasite control and formulations for parasiticides are described below.

(Formulation 6: Granulated Powder)

Five parts of the sufonylaminobenzamide compound of the present invention was dissolved in an organic solvent to obtain a solution, the solution was sprayed onto 94 parts of kaolin and 1 part of white carbon, and the solvent was then evaporated under reduced pressure. This type of granulated powder can be mixed with animal feed.

(Formulation 7: Injection)

From 0.1 to 1 part of the sufonylaminobenzamide compound of the present invention and 99 to 99.9 parts of peanut oil were mixed together uniformly, and the resulting mixture was then filter-sterilized using a sterilizing filter.

(Formulation 8: Pour-on Agent)

Five parts of the sufonylaminobenzamide compound of the present invention, 10 parts of a myristate ester and 85 parts of isopropanol were mixed together uniformly to obtain a pour-on agent.

(Formulation 9: Spot-on Agent)

From 10 to 15 parts of the sufonylaminobenzamide compound of the present invention, 10 parts of a palmitate ester and 75 to 80 parts of isopropanol were mixed together uniformly to obtain a spot-on agent.

(Formulation 10: Spray-on Agent)

One part of the sufonylaminobenzamide compound of the present invention, 10 parts of propylene glycol and 89 parts of isopropanol were mixed together uniformly to obtain a spray-on agent.

Examples of the compound are described below in order to describe the present invention in more detail. However, the present invention is in no way limited by the example compounds presented below.

Example 1

Synthesis of 4-(trifluoromethyl)-N-[4-(trifluoromethyl)phenyl]-2-(trifluoromethylsulfonylamino)benzamide (Compound Number: a-9)

Step 1

Synthesis of methyl 2-amino-4-(trifluoromethyl)benzoate

First, 4.10 g of 2-amino-4-(trifluoromethyl)benzoic acid was dissolved in 70 ml of methanol, and 12 ml of thionyl chloride was then added dropwise to the solution at 0° C. The temperature was then raised, and the reaction mixture was stirred for 12 hours under reflux conditions. After cooling to room temperature, the reaction solution was concentrated under reduced pressure, and the residue was dissolved in water and ethyl acetate. The resulting organic phase was washed with a saturated solution of sodium bicarbonate, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was then concentrated under reduced pressure to obtain 3.70 g (yield: 85%) of the target product.

The ¹H-NMR of the obtained target product is shown below.

¹H-NMR (400 MHz, CDCl₃): δ 7.94 (d, 1H), 6.89 (s, 1H), 6.83 (d, 1H), 5.90 (brs, 2H), 3.89 (s, 3H).

Step 2

Synthesis of methyl 4-(trifluoromethyl)-2-(trifluoromethyl sulfonylamino)benzoate

First, 4.92 g of methyl 2-amino-4-(trifluoromethyl)benzoate and 4.55 g of triethylamine were dissolved in 75 ml of chloroform, and 12.7 g of trifluoromethanesulfonic anhydride was then added dropwise to the solution at 0° C. The temperature was then raised to room temperature, and the reaction solution was stirred for 7 hours. The reaction solution was then poured into water and extracted with chloroform. The thus obtained organic phase was washed with a saturated solution of sodium bicarbonate, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was then concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography to obtain 5.80 g (yield: 74%) of the target product.

The ¹H-NMR of the obtained target product is shown below.

¹H-NMR (400 MHz, CDCl₃): δ 11.37 (s, 1H), 8.19 (d, 1H), 8.02 (s, 1H), 7.46 (d, 1H), 3.98 (s, 3H).

Step 3

Synthesis of 4-(trifluoromethyl)-2-(trifluoromethylsulfonylamino)benzoic acid

First, 5.80 g of methyl 4-(trifluoromethyl)-2-(trifluoromethylsulfonylamino)benzoate was dissolved in 30 ml of tetrahydrofuran, and 13 ml of a 4N aqueous solution of sodium hydroxide was added at room temperature. The temperature was then raised to 80° C., and the reaction solution was stirred for 2 hours. After cooling to room temperature, the reaction solution was poured into water, and diethyl ether was added to achieve a phase separation. Dilute hydrochloric acid was added to the obtained aqueous phase under cooling to produce an acidic state, and an extraction was then performed with ethyl acetate. The thus obtained organic phase was washed with a saturated saline solution, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was then concentrated under reduced pressure to obtain 4.56 g (yield: 82%) of the target product.

The ¹H-NMR of the obtained target product is shown below.

¹H-NMR (400 MHz, DMSO-d₆): δ 8.08 (d, 1H), 7.85 (s, 1H), 7.40 (d, 1H)

Step 4

Synthesis of 4-(trifluoromethyl)-N-[4-(trifluoromethyl)phenyl]-2-(trifluoromethylsulfonylamino)benzamide

First, 0.40 g of 4-(trifluoromethyl)-2-(trifluoromethylsulfonylamino)benzoic acid was dissolved in 4 ml of thionyl chloride, and the solution was stirred for 2 hours under reflux conditions. The reaction solution was then concentrated under reduced pressure, and the residue was dissolved in 15 ml of chloroform. Subsequently, 0.23 g of 4-trifluoromethylaniline was added at 0° C., and 0.30 g of sodium bicarbonate was then added. The temperature as then raised to room temperature, and the reaction mixture was stirred for 3 hours. The reaction mixture was then concentrated under reduced pressure, and the residue was dissolved in water and ethyl acetate. The thus obtained organic phase was washed with a saturated saline solution, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was then concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography to obtain 0.44 g (yield: 77%) of the target product.

The ¹H-NMR of the obtained target product is shown below.

¹H-NMR (400 MHz, DMSO-d₆): δ 13.50 (s, 1H), 8.21 (d, 1H), 7.86 (s, 1H), 7.81 (d, 2H), 7.71 (d, 2H), 7.23 (d, 1H).

A part of compounds of the present invention produced using a similar method to the example described above are shown in Table 1 to Table 2. Table 1 shows the substituents in compounds represented by formula (I-1). Table 2 shows the substituents in compounds represented by formula (I-2). The physical state or melting point (m.p.) is also shown in the tables to indicate the physical property of each compound. In the tables, Me represents a methyl group, Et represents an ethyl group, and ⁱPr represents an isopropyl group.

TABLE 1
Compound
number	R1	R2	R3	R4	R5	R6	R7	G	Ar	Physical property
a-1	H	H	Cl	H	CF3	H	H	O	3,5-(CF3)2-phenyl	amorphous
a-2	H	H	CF3	H	CF3	H	H	O	3-CF3-4-F-phenyl	m.p. 187-189° C.
a-3	H	H	CF3	H	CF3	H	H	O	3,5-(CF3)2-phenyl	amorphous
a-4	H	H	CF3	H	CF3	H	H	O	4-CF3-phenyl	m.p. 212-214° C.
a-5	H	H	Cl	H	CF3	H	Me	O	3,5-(CF3)2-phenyl	m.p. 148-150° C.
a-6	H	H	F	H	CF3	H	H	O	3,5-(CF3)2-phenyl	amorphous
a-7	H	H	CF3	H	CF3	H	H	O	2-Cl-4-CF3-phenyl	m.p. 180-182° C.
a-8	H	H	CF3	H	CF3	H	H	O	5-CF3-pyridin-2-yl	m.p. 220° C. up
a-9	H	H	CF3	H	CF3	H	H	O	3-F-5-CF3-phenyl	m.p. 179-181° C.
a-10	H	H	CF3	H	CF3	H	H	O	3-Cl-4-CF3-phenyl	m.p. 203-205° C.
a-11	H	H	CF3	H	CF3	H	H	O	2-F-5-CF3-phenyl	m.p. 172-174° C.
a-12	H	H	CF3	H	CF3	H	H	O	3-OCF3-phenyl	amorphous
a-13	H	H	CF3	H	CF3	H	H	O	4-Me-phenyl	m.p. 192-194° C.
a-14	H	H	CF3	H	CF3	H	H	O	4-Cl-phenyl	m.p. 198-200° C.
a-15	H	H	CF3	H	CF3	H	H	O	4-OCF3-phenyl	amorphous
a-16	H	F	F	H	CF3	H	H	O	3-CF3-4-F-phenyl	m.p. 172-174° C.
a-17	H	H	Me	H	CF3	H	H	O	3-CF3-4-F-phenyl	m.p. 176-178° C.
a-18	H	H	CF3	H	CF3	H	H	O	2,6-Cl2-4-CF3-phenyl	m.p. 194-195° C.
a-19	H	H	CF3	H	CF3	H	H	O	5-(1,1,1,3,3,3-	m.p. 220° C. up
									hexafluoropropan-2-
									yl)thiazol-2-yl
a-20	H	H	CF3	H	CF3	H	H	O	2-Me-4-	m.p. 188-190° C.
									(perfluoropropan-2-yl)-
									phenyl
a-21	H	H	CF3	H	CF3	Me	H	O	3-CF3-4-F-phenyl	m.p. 178-179° C.
a-22	H	H	CF3	H	CF3	H	H	O	3,4-Cl2-phenyl	m.p. 193-195° C.
a-23	H	H	CF3	H	CF3	H	H	O	3-Cl-5-CF3-pyridin-2-yl	m.p. 220° C. up
a-24	H	H	OCF3	H	CF3	H	H	O	4-OCF3-phenyl	m.p. 172-175° C.
a-25	H	H	OCF3	H	CF3	H	H	O	3-CF3-4-F-phenyl	m.p. 165-168° C.
a-26	H	H	OCF3	H	CF3	H	H	O	4-CF3-phenyl	m.p. 176-179° C.
a-27	H	H	CF3	H	CF3	Me	H	O	4-OCF3-phenyl	m.p. 167-168° C.
a-28	H	H	CF3	H	CF3	H	H	O	4-SF5-phenyl	m.p. 220-222° C.
a-29	H	H	Br	H	CF3	H	H	O	4-OCF3-phenyl	amorphous
a-30	H	H	CF3	H	CH2CF3	H	H	O	4-OCF3-phenyl	m.p. 185-188° C.
a-31	H	H	1H-1,2,4-triazol-1-	H	CF3	H	H	O	4-OCF3-phenyl	m.p. 220° C. up
			yl
a-32	H	H	6-Cl-pyridin-3-yl	H	CF3	H	H	O	4-OCF3-phenyl	m.p. 199-201° C.
a-33	H	H	CF3	H	CHF2	H	H	O	4-OCF3-phenyl	m.p. 127-129° C.
a-34	H	H	6-CF3-pyridin-3-yl	H	CF3	H	H	O	4-OCF3-phenyl	m.p. 170-172° C.
a-35	H	H	4-CF3-phenyl	H	CF3	H	H	O	4-OCF3-phenyl	m.p. 152-154° C.
a-36	H	H	CN	H	CF3	H	H	O	4-CF3-phenyl	amorphous
a-37	H	H	CF3	H	CF3	H	H	O	3-CF3-4-CN-phenyl	m.p. 220° C. up
a-38	H	H	CN	H	CH2CF3	H	H	O	4-CF3-phenyl	m.p. 220° C. up
a-39	H	H	CF3	H	CF3	H	H	O	4-CN-phenyl	m.p. 220° C. up
a-40	H	H	CN	H	CF3	H	H	O	4-CN-phenyl	m.p. 220° C. up
a-41	H	H	Cl	H	CF3	H	H	O	3-CF3-4-F-phenyl	amorphous
a-42	H	H	2-Cl-4-CF3-phenyl	H	CF3	H	H	O	4-OCF3-phenyl	amorphous
a-43	H	H	CF3	H	CF3	H	H	O	4-SCF3-phenyl	m.p. 185-187° C.
a-44	H	H	CF3	H	CF3	H	H	O	3-(1H-1,2,4-triazol-1-yl)phenyl	m.p. 220° C. up
a-45	H	H	CF3	H	CF3	H	H	O	4-(3-Me-1,2,4-oxadiazol-	m.p. 220° C. up
									5-yl)phenyl
a-46	H	H	CF3	H	CF3	H	H	O	4-(5-Me-1,3,4-oxadiazol-	m.p. 220° C. up
									2-yl)phenyl
a-47	H	H	CF3	H	CF3	H	H	O	pyridin-3-yl	m.p. 220° C. up
a-48	H	H	CF3	H	CF3	H	H	O	pyridin-4-yl	m.p. 220° C. up
a-49	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-Br-phenyl	m.p. 220° C. up
a-50	H	H	CF3	H	CF3	H	H	O	4-NO2-phenyl	m.p. 220° C. up
a-51	H	H	CF3	H	CF3	H	H	O	2-CN-4-Cl-phenyl	m.p. 230° C. up
a-52	H	H	CF3	H	CF3	H	H	O	2-CONHMe-4-Cl-phenyl	m.p. 230° C. up
a-53	H	H	CF3	H	CF3	H	H	O	2-F-4-CN-phenyl	m.p. 230° C. up
a-54	H	H	CF3	H	CF3	H	H	O	2-F-4-CF3-phenyl	amorphous
a-55	H	H	CF3	H	CF3	H	H	O	2-CF3-4-Cl-phenyl	amorphous
a-56	H	H	CF3	H	CF3	H	H	O	2-OCH2CF3-pyridin-4-yl	amorphous
a-57	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-F-phenyl	m.p. 135-137° C.
a-58	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-CF3-phenyl	m.p. 127-130° C.
a-59	H	H	CF3	H	CF3	H	H	O	2-OEt-4-CF3-phenyl	m.p. 220° C. up
a-60	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-Cl-phenyl	m.p. 220° C. up
a-61	H	H	CF3	H	CF3	H	H	O	2-COOEt-4-Br-phenyl	m.p. 195-197° C.
a-62	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-I-phenyl	m.p. 220° C. up
a-63	H	H	CF3	H	CF3	H	H	O	2-COOMe-5-CF3-phenyl	m.p. 132-134° C.
a-64	H	H	CF3	H	CF3	H	H	O	3-F-4-CF3-phenyl	amorphous
a-65	H	H	CF3	H	CF3	H	H	O	2-COOiPr-4-Br-phenyl	m.p. 142-144° C.
a-66	H	H	CF3	H	CF3	H	H	O	2-COEt-4-CF3-phenyl	m.p. 105-107° C.
a-67	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-CN-phenyl	m.p. 218-220° C.
a-68	H	H	CF3	H	CF3	H	H	O	2-Cl-4-Br-phenyl	m.p. 181-183° C.
a-69	H	H	CF3	H	CF3	H	H	O	3-Cl-4-Br-phenyl	amorphous
a-70	H	H	CF3	H	CF3	H	H	O	3-CF3-4-Cl-phenyl	amorphous
a-71	H	H	CF3	H	CF3	H	H	O	2-COOMe-4,6-Cl2-phenyl	amorphous
a-72	H	H	CF3	H	CF3	H	H	O	3-COOMe-4-Cl-phenyl	m.p. 217-219° C.
a-73	H	H	Br	H	CF3	H	H	O	2-COOMe-4-Br-phenyl	m.p. 171-173° C.
a-74	H	H	CF3	H	CF3	H	H	O	4-Br-2-(4,5-dihydrooxazol-2-yl)-	m.p. 220° C. up
									phenyl
a-75	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-NO2-phenyl	m.p. 174-176° C.
a-76	H	H	CF3	H	CF3	H	H	O	4-Br-2-(1H-pyrazol-1-yl)-phenyl	m.p. 151-153° C.
a-77	H	H	CF3	H	CF3	H	H	O	2-SO2Me-4-Br-phenyl	m.p. 215-217° C.
a-78	H	H	CF3	H	CF3	H	H	O	2-COOMe-4,5-F2-phenyl	m.p. 177-180° C.
a-79	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-I-5-Cl-	m.p. 170-172° C.
									phenyl
a-80	H	H	CF3	H	CF3	H	H	O	2-COOMe-4,5-Cl2-phenyl	m.p. 154-156° C.
a-81	H	H	CF3	H	CF3	H	H	O	5-CF3-2-(1H-pyrazol-1-	m.p. 164-167° C.
									yl)-phenyl
a-82	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-CF3-5-Cl-	m.p. 172-174° C.
									phenyl
a-83	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-Br-5-Cl-phenyl	m.p. 163-165° C.
a-84	H	CF3	Cl	H	CF3	H	H	O	2-COOMe-4-Br-phenyl	m.p. 220° C. up
a-85	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-Br-5-F-phenyl	m.p. 163-165° C.
a-86	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-CF3-5-F-	m.p. 170-172° C.
									phenyl
a-87	H	F	F	H	CF3	H	H	O	2-COOMe-4,5-F2-phenyl	m.p. 220° C. up
a-88	H	Br	Cl	H	CF3	H	H	O	2-COOMe-4,5-F2-phenyl	m.p. 220° C. up
a-89	H	H	CF3	H	CF3	H	H	O	2-COOMe-5-NO2-phenyl	m.p. 163-165° C.
a-90	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-Cl-5-F-	m.p. 220° C. up
									phenyl
a-91	H	H	NO2	H	CF3	H	H	O	2-COOMe-4,5-F2-phenyl	m.p. 220-222° C.
a-92	H	H	CF3	H	CF3	H	H	O	2-COOMe-5-Cl-phenyl	m.p. 131-133° C.
a-93	H	F	F	H	CF3	H	H	O	2-COOMe-5-CF3-phenyl	m.p. 125-128° C.
a-94	H	H	CF3	H	CF3	H	H	O	2-COOMe-5-F-phenyl	m.p. 198-200° C.
a-95	H	H	CF3	H	CF3	H	H	O	6-Cl-4-COOMe-pyridin-3-yl	m.p. 168-170° C.
a-96	H	H	CF3	H	CF3	H	H	O	2-Cl-5-COOMe-pyridin-4-yl	m.p. 183-185° C.
a-97	H	Cl	Cl	H	CF3	H	H	O	2-COOMe-4,5-F2-phenyl	m.p. 220° C. up
a-98	H	F	CF3	H	CF3	H	H	O	2-COOMe-4,5-F2-phenyl	m.p. 220° C. up
a-99	H	CF3	F	H	CF3	H	H	O	2-COOMe-4,5-F2-phenyl	m.p. 220° C. up
a-100	H	H	6-CF3-pyridin-	H	CF3	H	H	O	2-COOMe-4,5-F2-phenyl	m.p. 195-197° C.
			3-yl
a-101	H	H	CF3	H	CF3	H	H	O	5-CF3-2-(1H-1,2,4-	m.p. 220° C. up
									triazol-1-yl)-phenyl
a-102	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-Br-6-F-	m.p. 178-180° C.
									phenyl
a-103	H	H	CF3	H	CF3	H	H	O	2-NO2-4-CF3-phenyl	m.p. 177-179° C.
a-104	H	H	CF3	H	CF3	H	H	O	2-COOMe-3-Cl-phenyl	m.p. 181-184° C.
a-105	H	H	CF3	H	CF3	H	H	O	2-COOMe-4,6-F2-phenyl	m.p. 152-154° C.
a-106	H	H	CF3	H	CF3	H	H	O	2-COOMe-4,5,6-F3-phenyl	m.p. 160-162° C.
a-107	H	H	CF3	H	CF3	H	H	O	2-COOMe-3,4,5,6-F4-	m.p. 182-184° C.
									phenyl
a-108	H	H	CF3	H	CF3	H	H	O	2-NO2-4,5-F2-phenyl	m.p. 158-161° C.
a-109	H	H	CF3	H	CF3	H	H	O	2-COOMe-4-OCF3-phenyl	m.p. 210-212° C.
a-110	H	F	F	H	CF3	H	H	O	2-COOMe-4-OCF3-phenyl	m.p. 127-129° C.
a-111	H	F	F	H	CF3	H	H	O	2-COOMe-4-CF3-phenyl	m.p. 128-130° C.
a-112	H	Br	Cl	H	CF3	H	H	O	2-COOMe-4-CF3-phenyl	m.p. 220° C. up
a-113	H	F	F	H	CF3	H	H	O	2-COOMe-4-NO2-phenyl	m.p. 220° C. up
a-114	H	H	CF3	H	CF3	H	H	O	2-COOMe-3-Cl-4-Br-	m.p. 208-210° C.
									phenyl
a-115	H	H	CF3	H	CF3	H	H	O	2-(CH═NOMe)-4-Cl-phenyl	m.p. 220° C. up
a-116	H	H	CF3	H	CF3	H	H	O	2,4,5-F3-phenyl	m.p. 185-187° C.
a-117	H	H	Cl	H	CF3	H	H	O	2-COOMe-4,5-F2-phenyl	m.p. 156-158° C.
a-118	H	H	6-CF3-pyridin-	H	CF3	H	H	O	4-CF3-phenyl	m.p. 220-223° C.
			3-yl
a-119	H	H	6-CF3-pyridin-	H	CF3	H	H	O	3-F-4-CF3-phenyl	m.p. 220° C. up
			3-yl
a-120	H	H	6-CF3-pyridin-	H	CF3	H	H	O	3-CF3-4-F-phenyl	m.p. 213-215° C.
			3-yl
a-121	H	H	6-CF3-pyridin-	H	CF3	H	H	O	4-NO2-phenyl	m.p. 220° C. up
			3-yl
a-122	H	CF3	F	H	CF3	H	H	O	4-CF3-phenyl	m.p. 220° C. up
a-123	H	F	CF3	H	CF3	H	H	O	4-CF3-phenyl	amorphous
a-124	H	Br	Cl	H	CF3	H	H	O	4-CF3-phenyl	m.p. 220° C. up
a-125	H	H	CF3	H	CF3	H	H	O	3-COOMe-thiophen-	m.p. 210-213° C.
									2-yl
a-126	H	H	CF3	H	CF3	H	H	O	2-COOMe-3-F-4-Br-phenyl	m.p. 185-187° C.
a-127	H	F	F	H	CF3	H	H	O	4-CF3-phenyl	amorphous
a-128	H	Cl	Cl	H	CF3	H	H	O	4-CF3-phenyl	amorphous
a-129	H	Cl	F	H	CF3	H	H	O	4-CF3-phenyl	amorphous
a-130	H	H	CF3	H	CF3	H	H	O	2-NHCOMe-5-CF3-phenyl	m.p. 220° C. up
a-131	H	Br	Cl	H	CF3	H	H	O	2-COOMe-5-CF3-phenyl	m.p. 160-162° C.
a-132	H	Cl	Br	H	CF3	H	H	O	2-COOMe-4,5-F2-phenyl	m.p. 220° C. up
a-133	H	H	CF3	H	CF3	H	H	O	2-COMe-4-Br-phenyl	m.p. 151-153° C.
a-134	H	H	CF3	H	CF3	H	H	O	2-COMe-5-CF3-phenyl	m.p. 113-115° C.
a-135	H	H	CF3	H	CF3	H	H	O	2-(1H-pyrazol-1-yl)-4-	m.p. 223-225° C.
									CF3-phenyl
a-136	H	Br	Cl	H	CF3	H	H	O	2-(1H-pyrazol-1-yl)-5-	m.p. 199-202° C.
									CF3-phenyl
a-137	H	Cl	F	H	CF3	H	H	O	2-COOMe-5-CF3-phenyl	m.p. 150-152° C.
a-138	H	H	CF3	H	CF3	H	H	O	3,4-F2-phenyl	amorphous
a-139	H	H	CF3	H	CF3	H	H	O	2-(1,3,4-oxadiazol-2-	m.p. 180-182° C.
									yl)-5-CF3-phenyl
a-140	H	H	CF3	H	CF3	H	H	O	2-(4,5-dihydrooxazol-	m.p. 222-225° C.
									2-yl)-5-CF3-phenyl
a-141	H	H	Cl	H	CF2CF2CF2CF3	H	H	O	3-CF3-4-F-phenyl	amorphous
a-142	H	H	CF3	H	CF2CF2CF2CF3	H	H	O	4-OCF3-phenyl	amorphous
a-143	H	Br	Cl	H	CF3	H	H	O	3,4-F2-phenyl	m.p. 227-229° C.

TABLE 2

Compound

Physical

number

R1

R2

R3

R4

R5

R6

R7

R8

R9

G

Ar

property

b-1

H

H

CF3

H

CF3

H

H

H

H

O

4-Cl-phenyl

m.p. 127-129° C.

b-2

H

H

CF3

H

CF3

H

H

Me

Me

O

4-Cl-phenyl

amorphous

b-3

H

H

CF3

H

CF3

H

H

iPr

H

O

4-Cl-phenyl

m.p. 168-170° C.

b-4

H

H

CF3

H

CF3

H

H

Me

H

O

3-Cl-5-CF3-pyridin-2-yl

amorphous

b-5

H

H

CF3

H

CF3

H

H

Me

H

O

5-CF3-pyridin-2-yl

m.p. 163-165° C.

b-6

H

H

CF3

H

CF3

H

H

Et

H

O

5-CF3-pyridin-2-yl

amorphous

Among the compounds shown in Table 1 to Table 2, those compounds having a physical property described as “viscous oil” or “amorphous” were subjected to a ¹H-NMR (DMSO-d₆) measurement. The measurement results are shown in Table 3.

TABLE 3
Compound
number 1H-NMR (DMSO-d6, δ ppm)
a-1    8.80 (brs, 1H), 8.19 (s, 2H), 8.02 (d, 1H), 7.75 (s, 1H),
       7.53 (s, 1H), 7.00 (d, 1H)
a-3    8.21 (s, 2H), 8.18 (d, 1H), 7.82 (s, 1H), 7.77 (s, 1H),
       7.24 (d, 1H)
a-6    8.80 (brs, 1H), 8.19 (s, 2H), 8.08 (m, 1H), 7.73 (s, 1H),
       7.25 (d, 1H), 6.78 (m, 1H)
a-12   8.20 (d, 1H), 7.90 (s, 1H), 7.85 (s, 1H), 7.48 (t, 1H),
       7.37 (d, 1H), 7.22 (d, 1H), 7.05 (d, 1H)
a-15   8.21 (d, 1H), 7.85 (s, 1H), 7.72 (d, 2H), 7.36 (d, 2H),
       7.22 (d, 1H)
a-29   7.94 (d, 1H), 7.69 (m, 3H), 7.34 (d, 2H), 7.11 (d, 1H)
a-36   13.40 (s, 1H), 8.77 (bs, 1H), 8.17 (d, 1H), 7.83 (m, 3H),
       7.79 (d, 2H), 7.33 (d, 1H)
a-41   13.40 (s, 1H), 8.21 (m, 1H), 8.02 (d, 1 H), 7.65 (m, 1H),
       7.51 (m, 2H), 6.97 (d, 1 H)
a-42   13.20 (bs, 1H), 8.10 (d, 1H), 7.95 (s, 1H), 7.77 (m, 3H),
       7.60 (d, 2H), 7.37 (d, 2H), 7.07 (d, 1H)
a-54   8.71 (t, 1H), 8.24 (d, 1H), 7.97 (s, 1H), 7.73 (d, 2H),
       7.56 (d, 1H), 7.22 (d, 1H)
a-55   8.20 (d, 1H), 7.98 (d, 1H), 7.90 (s, 1H), 7.74 (m, 2H),
       7.19 (d, 1H)
a-56   13.20 (s, 1H), 8.18 (d, 1H), 8.09 (d, 1H), 7.85 (s, 1H),
       7.27 (m, 2H), 7.09 (d, 1H), 4.95 (m, 2H)
a-64   8.20 (d, 1H), 7.93 (d, 1H), 7.85 (s, 1H), 7.77 (t, 1H),
       7.31 (d, 1H), 7.23 (d, 1H)
a-69   8.18 (d, 1H), 8.08 (d, 1H), 7.84 (s, 1H), 7.73 (d, 1H),
       7.32 (m, 1H), 7.21 (d, 1H)
a-70   8.31 (s, 1H), 8.19 (d, 1H), 7.84 (s, 1H), 7.71 (m, 2H),
       7.23 (d, 1H)
a-71   8.14 (d, 1H), 7.96 (s, 1H), 7.91 (d, 1H), 7.62 (d, 1H),
       7.18 (m, 1H)
a-123  13.51 (s, 1H), 7.93 (d, 1H), 7.86 (d, 1H), 7.80 (d, 2H),
       7.72 (d, 2H)
a-127  13.49 (s, 1H), 7.93 (d, 1H), 7.77 (d, 2H), 7.70 (d, 2H),
       7.54 (m, 1H)
a-128  13.33 (s, 1H), 8.11 (s, 1H), 7.78 (d, 2H), 7.20 (m, 3H)
a-129  13.35 (s, 1H), 8.10 (d, 1H), 7.76 (d, 2H), 7.71 (d, 2H),
       7.43 (d, 1H)
a-138  13.39 (s, 1H), 8.19 (d, 1H), 7.91 (m, 1H), 7.83 (s, 1H),
       7.43 (m, 1H), 7.21 (d, 1H), 7.14 (m, 1 H)
a-141  13.38 (s, 1H), 8.17 (m, 1H), 8.01 (d, 1H), 7.65 (m, 1H),
       7.61 (s, 1H), 7.53 (t, 1H), 7.97 (d, 1H)
a-142  13.30 (s, 1H), 8.20 (d, 1H), 7.93 (s, 1H), 7.71 (d, 2H),
       7.36 (d, 2H), 7.22 (d, 1H)
b-2    11.12 (s, 1H), 7.97 (d, 1H), 7.83 (s, 1H), 7.30 (m, 4H),
       7.09 (d, 1H)
b-4    11.12 (d, 1H), 8.81 (s, 1H), 8.37 (s, 1H), 8.03 (d, 1H),
       7.79 (s, 1H), 7.12 (d, 1H), 5.55 (m, 1H), 1.42 (d, 3H)
b-6    11.08 (d, 1H), 8.88 (s, 1H), 8.10 (m, 1H), 8.03 (d, 1H),
       7.89 (s, 1H), 7.54 (d, 1H), 7.15 (d, 1H), 5.03 (m, 1H),
       1.95-1.87 (m, 2H), 0.91 (m, 3H)

As described above, the sufonylaminobenzamide compound of the present invention can be produced easily by using known chemical reactions such as those described in the example above. The fact that compounds not specifically disclosed in the present description, namely compounds substituted with various substituents which do not depart from the object and scope of the present invention, can be produced and used in accordance with the methods described above or similar methods will be readily understood by those skilled in the art on the basis of the disclosure within the present description.

[Biological Testing]

The test examples described below demonstrate that the sufonylaminobenzanmide compound of the present invention (hereafter also referred to as “the compound of the present invention”) is useful as the active constituent in a pest control agent. The units “parts” are based on weight.

(Preparation of Test Emulsion)

Five parts of the compound of the present invention, 93.6 parts of dimethylformamide and 1.4 parts of a polyoxyethylene alkyl aryl ether were mixed together and dissolved to obtain an emulsion (1) containing 5% of the active constituent.

The mortality rate was calculated using the following equation.Mortality rate (%)=(number of dead pests/number of test pests)×100

(Test Example 1) Efficacy Test Against Mythimna separata

First, 0.8 g of an artificial feed (Insecta LFS, manufactured by Nosan Corporation) and 1 μl of the emulsion (I) were mixed thoroughly, and 0.2 g of the resulting mixture was placed in each of the treatment areas of a plastic test container (volume: 1.4 ml) to complete preparation of a test feed.

Two second-instar larvae of Mythimna separata were inoculated into each treatment area, and the test container was sealed with a plastic lid. The sealed container was placed in a temperature-controlled room at 25° C., and the mortality rate and the amount of feed consumed were determined on the fifth day. The test was repeated. Further, a test performed under the same conditions, but with the exception of excluding the compound of the present invention from the emulsion (1), was used as a control.

Efficacy tests against Mythimna separata were conducted for the compounds having the compound numbers shown in Table 4. For all of the compounds, the mortality rate against Mythimna separata was 100%, or the amount of feed consumed was 10% or less of the amount of feed consumed in the control.

	TABLE 4
	a-1	a-22	a-41	a-65	a-86	a-113	a-133
	a-2	a-23	a-42	a-66	a-87	a-114	a-134
	a-3	a-24	a-46	a-67	a-88	a-115	a-135
	a-4	a-25	a-49	a-68	a-90	a-116	a-137
	a-7	a-26	a-50	a-69	a-92	a-117	a-138
	a-8	a-28	a-51	a-70	a-96	a-118	a-139
	a-9	a-29	a-53	a-71	a-97	a-119	a-141
	a-10	a-30	a-54	a-73	a-98	a-120	a-142
	a-11	a-31	a-55	a-75	a-99	a-121	a-143
	a-12	a-32	a-56	a-76	a-100	a-122	b-1
	a-13	a-33	a-57	a-78	a-103	a-123	b-2
	a-14	a-34	a-58	a-79	a-104	a-124	b-3
	a-15	a-35	a-59	a-80	a-105	a-126	b-4
	a-16	a-36	a-60	a-81	a-106	a-127	b-6
	a-18	a-37	a-61	a-82	a-109	a-128
	a-19	a-38	a-62	a-83	a-110	a-129
	a-20	a-39	a-63	a-84	a-111	a-131
	a-21	a-40	a-64	a-85	a-112	a-132

(Test Example 2) Efficacy Test Against Spodoptera litura

The emulsion (1) was diluted with water to achieve a concentration of the compound of the present invention of 125 ppm. Cabbage leaves were soaked in the diluted liquid for 30 seconds. These cabbage leaves were then placed in a Petri dish, and five second-instar larvae of Spodoptera litura were released into the dish. The Petri dish was placed in a temperature-controlled room at a temperature of 25° C. and a humidity of 60%. Mortality was investigated 6 days after larvae release, and the mortality rate was calculated. The test was repeated.

Efficacy tests against Spodoptera litura were conducted for the compounds having the compound numbers shown in Table 5. All of the compounds produced a mortality rate against Spodoptera litura of at least 80%.

	TABLE 5
	a-1	a-9	a-16	a-23	a-29	a-41	a-64
	a-2	a-10	a-18	a-24	a-30	a-42	b-2
	a-3	a-11	a-19	a-25	a-34	a-50	b-3
	a-4	a-12	a-20	a-26	a-35	a-54	b-4
	a-7	a-14	a-21	a-27	a-37	a-55	b-6
	a-8	a-15	a-22	a-28	a-39	a-56

(Test Example 3) Efficacy Test Against Plutella xylostella

The emulsion (I) was diluted with water to achieve a concentration of the compound of the present invention of 125 ppm. Cabbage leaves were soaked in the diluted liquid for 30 seconds. These cabbage leaves were then placed in a Petri dish, and five second-instar larvae of Plutella xylostella were released into the dish. The Petri dish was placed in a temperature-controlled room at a temperature of 25° C. and a humidity of 60%. Mortality was investigated 3 days after larvae release, and the mortality rate was calculated. The test was repeated.

Efficacy tests against Plutella xylostella were conducted for the compounds having the compound numbers shown in Table 6. All of the compounds produced a mortality rate against Spodoptera litura of at least 80%.

	TABLE 6
	a-1	a-22	a-32	a-40	a-54	a-67	b-6
	a-2	a-23	a-33	a-41	a-55	a-76
	a-3	a-24	a-34	a-42	a-56	a-78
	a-4	a-25	a-35	a-49	a-58	b-1
	a-7	a-26	a-36	a-50	a-64	b-2
	a-15	a-29	a-37	a-51	a-65	b-3
	a-21	a-30	a-39	a-53	a-66	b-4

(Test Example 4) Efficacy Test Against Meloidogyne incognita

(Clubroot Formation Suppression Test)

The emulsion (I) was diluted with water to achieve a concentration of the compound of the present invention of 125 ppm. A plastic container with a diameter of 5 cm was filled with 7 g of a culture medium, and cucumber seeds were planted. The culture medium was irrigated with 1 ml of the above dilute liquid, and then inoculated with 200 eggs of Meloidogyne incognita. The container was then placed in a temperature-controlled room at a temperature of 25° C. and a humidity of 60%, and after 14 days, the clubroot formation suppression ratio (%) relative to an untreated sample was calculated from the number of clubroots formed on the roots of the cucumber plants. The test was repeated.Clubroot formation suppression ratio (%)=(1−Nt/Nc)×100

Nt: Total number of club roots formed in two treated samples after 14 days

Nc: Total number of club roots formed in two untreated samples after 14 days

Efficacy tests against Meloidogyne incognita were conducted for the compounds having the compound numbers shown in Table 7. All of the compounds produced a clubroot formation suppression ratio against Meloidogyne incognita of at least 80%.

TABLE 7
a-1	a-16	a-40	a-59	a-74	a-87	a-102	a-121	a-136
a-2	a-22	a-41	a-60	a-75	a-88	a-103	a-122	a-137
a-3	a-24	a-42	a-61	a-76	a-90	a-109	a-123	a-138
a-4	a-26	a-49	a-62	a-78	a-91	a-110	a-124	a-139
a-6	a-28	a-50	a-63	a-79	a-92	a-111	a-126	a-141
a-7	a-29	a-51	a-64	a-80	a-93	a-112	a-127	a-143
a-8	a-32	a-53	a-67	a-81	a-95	a-113	a-128	b-4
a-9	a-34	a-54	a-68	a-82	a-96	a-115	a-129	b-5
a-10	a-35	a-55	a-69	a-83	a-97	a-116	a-131	b-6
a-11	a-36	a-56	a-70	a-84	a-98	a-118	a-132
a-14	a-38	a-57	a-71	a-85	a-99	a-119	a-134
a-15	a-39	a-58	a-73	a-86	a-100	a-120	a-135

(Test Example 5) Efficacy Test Against Meloidogyne incognita (In Vitro Test)

Two hundred μL of a suspension containing about 50 second-instar larvae (L2) of Meloidogyne incognita was dispensed into each well of a 96-well microplate, and 0.2 μL of a 10,000 ppm dimethylsulfoxide solution of the compound of the present invention was injected into each well to achieve a final concentration of 50 ppm. Mortality was investigated after 2 days treatment at 15° C., and the nematode mortality rate was calculated. Observation was performed for 10 seconds, and those individuals that showed no movement in that time were deemed to be dead. The test was repeated.

Efficacy tests against Meloidogyne incognita were conducted for the compounds having the compound numbers shown in Table 8. All of the compounds produced a nematode mortality (still) rate against Meloidogyne incognita of at least 80%.

TABLE 8
a-1	a-17	a-37	a-58	a-76	a-92	a-113	a-131
a-2	a-18	a-38	a-59	a-78	a-93	a-115	a-132
a-3	a-22	a-39	a-60	a-79	a-95	a-116	a-134
a-4	a-24	a-40	a-61	a-80	a-96	a-118	a-135
a-6	a-25	a-41	a-62	a-81	a-97	a-119	a-136
a-7	a-26	a-42	a-63	a-82	a-98	a-120	a-137
a-8	a-28	a-49	a-64	a-83	a-99	a-121	a-138
a-9	a-29	a-50	a-67	a-84	a-100	a-122	a-139
a-10	a-30	a-51	a-68	a-85	a-102	a-123	a-141
a-11	a-32	a-53	a-69	a-86	a-103	a-124	a-143
a-12	a-33	a-54	a-70	a-87	a-109	a-126	b-1
a-14	a-34	a-55	a-71	a-88	a-110	a-127	b-4
a-15	a-35	a-56	a-73	a-90	a-111	a-128	b-5
a-16	a-36	a-57	a-75	a-91	a-112	a-129

(Test Example 6) Efficacy Test Against Caenorhabditis elegans (In Vitro Test)

Two hundred μL of a suspension containing about 50 mixed instars of Caenorhabditis elegans was dispensed into each well of a 96-well microplate, and 0.2 μL of a 10,000 ppm dimethylsulfoxide solution of the compound of the present invention was injected into each well to achieve a final concentration of 50 ppm. Mortality was investigated after 2 days treatment at 25° C., and the nematode mortality rate was calculated. Observation was performed for 10 seconds, and those individuals that showed no movement in that time were deemed to be dead. The test was repeated.

Efficacy tests against Caenorhabditis elegans were conducted for the compounds having the compound numbers shown in Table 9. All of the compounds produced a nematode mortality rate against Caenorhabditis elegans of at least 80%.

TABLE 9
a-1	a-16	a-33	a-53	a-68	a-103	a-118	a-137
a-2	a-18	a-34	a-54	a-69	a-104	a-119	a-138
a-3	a-19	a-35	a-55	a-70	a-106	a-120	a-142
a-4	a-20	a-36	a-56	a-75	a-107	a-121	a-143
a-6	a-22	a-37	a-57	a-76	a-109	a-122	b-4
a-7	a-24	a-38	a-58	a-78	a-110	a-123	b-5
a-8	a-25	a-39	a-60	a-79	a-111	a-124	b-6
a-9	a-26	a-40	a-61	a-88	a-112	a-126
a-10	a-28	a-41	a-62	a-90	a-113	a-127
a-11	a-29	a-42	a-63	a-93	a-114	a-128
a-12	a-30	a-49	a-64	a-97	a-115	a-129
a-14	a-31	a-50	a-66	a-98	a-116	a-132
a-15	a-32	a-51	a-67	a-99	a-117	a-133

(Test Example 7) Efficacy Test Against Heterodera glycines (In Vitro Test)

Two hundred μL of a suspension containing about 50 second-instar larvae (L2) of Heterodera glycines was dispensed into each well of a 96-well microplate, and 0.2 μL of a 10,000 ppm dimethylsulfoxide solution of the compound of the present invention was injected into each well to achieve a final concentration of 10 ppm. Mortality was investigated after 3 days treatment at 25° C., and the nematode mortality rate was calculated. Observation was performed for 10 seconds, and those individuals that showed no movement in that time were deemed to be dead. The test was repeated.

Efficacy tests against Heterodera glycines were conducted for the compounds having the compound numbers shown in Table 10. All of the compounds produced a nematode mortality rate against Heterodera glycines of at least 80%.

	TABLE 10
	a-2	a-63	a-135
	a-4	a-76	a-136
	a-15	a-78
	a-58	a-134

(Test Example 8) Contact/Ingestion Efficacy Test Against Aedes aegypti Larvae

A DMSO solution of the compound of the present invention was diluted with water to obtain a 125 μM dilute solution. Ten first-instar larvae of Aedes aegypti were placed in each well of a 96-well microtiter plate, the above dilute liquid was added in a ratio of 1/10, and a test was conducted at a final concentration of 12.5 μM. The samples were incubated in a temperature-controlled room (28° C., 80% RH), and after 48 hours of treatment with the compound, the mortality of the larvae was investigated. The test was repeated.

Contact/ingestion efficacy tests against Aedes aegypti larvae were conducted for the compounds having the compound numbers shown in Table 11. All of the compounds produced a mortality rate against Aedes aegypti of at least 80%.

	TABLE 11
	a-1	a-9	a-18	a-26	a-34	a-42	a-87
	a-2	a-10	a-19	a-28	a-35	a-49	a-88
	a-3	a-11	a-20	a-29	a-36	a-58	a-93
	a-4	a-12	a-22	a-30	a-37	a-60	a-100
	a-6	a-14	a-23	a-31	a-39	a-73	b-1
	a-7	a-15	a-24	a-32	a-40	a-76	b-2
	a-8	a-16	a-25	a-33	a-41	a-78	b-3

(Test Example 9) Efficacy Tests Against Ascaridia galli and Oesophagostomum Dentatum

Using the gut-welling larval stages of two parasitic worms: namely, the third stage larvae (L3) of Ascaridia galli, and the third and fourth stage larvae (L3 and L4 respectively) of Oesophagostomum dentatum, the bioactivity of compounds of the present invention were investigated in vitro. When conducting these tests, DMSO solutions of the compounds of the present invention were prepared at various concentrations and incubated in the wells of a 96-well microtiter plate. Subsequently, 20 parasitic worm larvae were inoculated into each well. The bioactivity was determined by inspection under a microscope. The inspection under a microscope included evaluations of the mortality rate, injury, motility, development progression, and neutral red uptake by the larvae compared with a DMSO control. The bioactivity was defined by the minimum effective concentration (MEC), which represents the concentration at which at least one larva dies, is injured, undergoes a change in motility or a change in development progression, or exhibits no neutral red uptake.

Efficacy tests against Ascaridia galli and Oesophagostomum dentatum were conducted for the compounds having the compound numbers shown in Table 12. All of the compounds exhibited activity against at least one type of target parasitic worm at an MEC of 25 μM or less.

TABLE 12
a-2	a-14	a-25	a-34	a-58	a-93
a-3	a-15	a-26	a-35	a-60	a-100
a-7	a-16	a-28	a-36	a-73	b-1
a-8	a-17	a-29	a-37	a-76
a-9	a-21	a-30	a-41	a-78
a-10	a-23	a-32	a-42	a-87
a-13	a-24	a-33	a-49	a-88

(Test Example 10) Efficacy Test Against Haemonchus contortus

Third stage larvae (L3) of Haemonchus contortus were collected from the feces of infected sheep, and the bioactivity of compounds of the present invention were investigated in vitro. When conducting this test, DMSO solutions of the compounds of the present invention were prepared at various concentrations and incubated in the wells of a 96-well microtiter plate. Subsequently, 100 parasitic worm larvae were inoculated into each well. The bioactivity was determined by inspection under a microscope. The inspection under a microscope included evaluations of the mortality rate, injury, motility, development progression, and neutral red uptake by the larvae compared with a DMSO control. The bioactivity was defined by the minimum effective concentration (MEC), which represents the concentration at which at least one larva dies, is injured, undergoes a change in motility or a change in development progression, or exhibits no neutral red uptake.

Efficacy tests against Haemonchus contortus were conducted for the compounds having the compound numbers shown in Table 13. All of the compounds exhibited activity against L3 larvae of Haemonchus contortus at an MEC of 25 μM or less.

	TABLE 13
	a-49	a-76	a-93
	a-58	a-78	a-100
	a-60	a-87
	a-73	a-88

(Test Example 11) Efficacy Test Against Dirofilaria immitis

Using the microfilarial stage and the fourth stage larvae (Mf and L4 respectively) of Dirofilaria immitis, the bioactivity of compounds of the present invention were investigated in vitro. The Mf was collected from the blood of infected dogs, and 500 microfilariae were inoculated into each well of a 96-well microtiter plate. The L4 larvae was obtained by allowing L3 larvae collected from infected mosquitoes to undergo a single molt, and 10 of these L4 larvae were inoculated into each well. Subsequently, a 10 mM DMSO solution of the compound of the present invention was prepared at various concentrations and added to each well in a ratio of 1/1,000, and a test was then conducted at a final concentration of 10 μM. Incubation was performed at 37° C. in an environment containing 5% carbon dioxide, and 72 hours after treatment with the compound, the mortality and growth inhibition were determined. The test was repeated.

An efficacy test against Dirofilaria immitis was conducted for the compound having the compound number a-26. At 10 μM, this compound exhibited a mortality rate or growth inhibition rate of at least 90% against both the Mf and L4 growth stages.

Based on the fact that compounds selected randomly from the compounds of the present invention all exhibited the types of effects described above, it is evident that the compounds of the present invention, including those compounds not exemplified above, have pest control effects, and in particular, insecticidal, miticidal and nematicidal effects or the like.

INDUSTRIAL APPLICABILITY

The present invention can provide a sufonylaminobenzamide compound that has pest control activity, and in particular, has excellent insecticidal, miticidal and/or nematicidal activity, exhibits excellent safety, and can be synthesized favorably on an industrial scale, and can also provide a pest control agent that contains this compound as an active constituent.

Claims

1. A compound represented by formula (I) or a salt thereof:

2. A pest control agent comprising at least one substance selected from the group consisting of the compound according to claim 1 and salts thereof as an active constituent.

3. A nematicide comprising at least one substance selected from the group consisting of the compound according to claim 1 and salts thereof as an active constituent.